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Helminth infections continue to threaten human and animal health worldwide. 
Dissection of the interactions between helminths and helminth-induced Th2 immunity 
is necessary for the development of effective prophylactic and therapeutic approaches 
to disease control. Trichinella spiralis is natural pathogen of humans and rodents, 
providing a valuable context for study of the relationships between Th2 immunity and 
parasitic worms. Eosinophilia is a hallmark of Th2 immunity in helminth infections, 
yet the roles of eosinophils in worm infection have remained elusive. Our early studies 
have revealed unexpected functions of eosinophils in T. spiralis infection. Rather than 
promoting clearance of parasites, eosinophils supported muscle larvae survival and 
growth by regulating local immunity. 
 The results presented here define the eosinophil-dependent mechanisms that 
protect muscle larvae against nitric oxide-mediated killing in primary infection. Our 
results demonstrate that early recruitment of eosinophils to sites of infection is 
essential for driving local immunity that promotes larval survival. Eosinophil-derived 
IL-10 expands IL-10+ myeloid dendritic cells and CD4+IL-10+ T cells that suppress 
iNOS expression and protect intracellular larvae. The results reveal a novel 
immunoregulatory function of eosinophils in helminth infection. 
  In secondary infection by T. spiralis, eosinophils are dispensable for intestinal 
immunity that clear adult worms while having a profound effect on the migration of 
newborn larvae. This interference limits further colonization of skeletal muscle. The 
protective effect is dependent on the presence of immune serum and reinforces the 
dogma that eosinophils adhere to larvae in the presences of antibodies.  
 Eosinophils regulate larval growth through a third distinct mechanism. Current 
results indicate that intrinsic STAT6 signaling of eosinophils and eosinophil-derived 
IL-4 are required for larval growth. Importantly, larval growth is supported by 
eosinophils independently of adaptive immunity. Gene expression array analysis of 
skeletal muscles of infected Rag1-/- mice revealed a signature compatible with muscle 
regeneration and a shift in the source of energy, indicating that eosinophils are likely 
promoting larval growth by regulating metabolism in local tissues, thereby creating a 
suitable microenvironment.  
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CHAPTER 1 
 
Functional versatility of eosinophils at the host-parasite interface* 
 
 
                                                 
* Lu Huang, Judith A. Appleton. Functional versatility of eosinophils at the host-
parasite interface. Invited review for Clinical and Experimental Allergy. In revision. 
 2 
Abstract 
Eosinophilia is a central feature of Th2 immune responses induced by 
infections with parasitic worms. Although early work showed that eosinophils could 
adhere to and damage parasite larvae in vitro, a definitive role for eosinophils during 
worm infection remained elusive until recently. Newly created mouse strains in which 
the eosinophil lineage is ablated serve as powerful tools for the study of eosinophil 
function in disease, but also in health. Particularly exciting are recent findings that 
show an expanded functional repertoire for eosinophils in tissue homeostasis and 
metabolism, processes that are intricately related to the establishment and maintenance 
of parasitic worms in their hosts. In this review, we describe the value and potential of 
novel mouse models for studying eosinophils, emphasizing results from studies that 
have revealed functional properties of eosinophils in healthy tissues that also may be 
important in worm infection. Following a summary of findings in support of tissue-
dependent eosinophil function in worm infection, we highlight experiments performed 
with Trichinella spiralis, in which eosinophils show considerable functional versatility 
by clearing parasites in one context and promoting parasite survival in another. 
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Introduction 
Parasites depend upon their hosts to compensate for lost functions that 
otherwise enable a free-living lifestyle. The host provides a supportive physical 
environment for growth, reproduction, and maturation, and the metabolic needs of the 
parasite are intricately linked to the metabolism of the host. Parasitic worms are highly 
complex, macroscopic, invertebrate animals that incorporate nervous, excretory, 
gastrointestinal, muscular, and reproductive systems. Their size and motility is such 
that tissue trauma is a common feature of infection, further complicating their 
dependence upon the host for a physical home that also meets their nutritional needs. 
In spite of the complexities of this dependence and associated physical disruption, 
parasitic worms often colonize their hosts for long periods.  
In parasitic infections of animals, a potent Th2-driven immune response is 
superimposed on the metabolic and physical interaction between host and worm. 
Effector mechanisms that clear worms from the body vary, likely depending upon the 
habitat and niche of the parasite. In some instances goblet cells are critical (1), in 
others mast cells (2) or antibodies (3-5) play important roles. These mediators may 
deprive the worm of energy or nutrients (1), or may disrupt the habitat (6). By a 
similarly varied array of mechanisms, worms evade or co-opt the immune response in 
order to complete their life cycles and be transmitted to the next host (7).  
The eosinophil has been a prominent but enigmatic cell type in the immune 
response to parasitic worms. Representing less than 5% of leukocytes in the peripheral 
blood, Th2-derived Interleukin-5 (IL-5) induces activation and recruitment of 
eosinophils to tissues (8), and eosinophilia can be dramatic during worm infection (9). 
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Eosinophils contain numerous granules that store preformed cytotoxic proteins, 
including major basic protein-1 (MBP-1) (10, 11) and eosinophil peroxidase (EPX) 
(12, 13), and have been shown to degranulate on and kill larvae in vitro (14-16). 
Hence it has been widely accepted that eosinophils are effector cells that function as a 
downstream arm of Th2 immunity in defense against parasitic worms. The availability 
of eosinophil-ablated mouse models has enabled experimentation that addresses the 
functions of eosinophils in vivo, revealing that eosinophils are sometimes dispensable 
and other times beneficial to certain parasitic worms. In the latter context, it is relevant 
to note that eosinophils demonstrate immunoregulatory functions by virtue of their 
secretion of a wide variety of immunomodulators, including cytokines, chemokines, 
and growth factors (17, 18). 
This review aims to summarize recent progress in our understanding of the role 
of eosinophils in worm infection. Many advances have been made possible by the 
availability of new mouse strains. In addition, we describe exciting findings relating to 
the role of eosinophils in processes that are relevant to parasitism, including tissue 
injury, metabolism, and antibody responses. Lastly, findings from mouse models of 
various helminth infections will be summarized, followed by a description of the 
versatility of eosinophils during Trichinella spiralis infection. 
 
Mouse models for studying eosinophils 
Early studies of eosinophil function in mouse models of worm infection relied 
upon antibody-mediated depletion of eosinophils or IL-5 (19, 20). Subsequently, 
mouse strains were engineered to be deficient in IL-5 (8), in eotaxins (21-23) or their 
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receptor CCR3 (21-24), or to overexpress IL-5 (IL-5Tg+) (25). Although expansion 
and recruitment of eosinophils are profoundly altered in these strains, the lineage is 
not ablated, which compromises the interpretation of negative results. The 
development of two eosinophil-ablation models, PHIL and ΔdblGATA (26, 27), 
enabled definitive experiments that both confirmed some prior findings but also 
revealed previously unknown properties of eosinophils. The two strains were 
engineered using different approaches. In PHIL mice, diphtheria toxin (DT) A chain 
was inserted downstream of the eosinophil peroxidase promoter (26). In contrast, 
ΔdblGATA mice bear a deletion of the high-affinity double GATA site in the GATA1 
promoter that blocks the development of eosinophil lineage (27). These strains, 
together with models developed earlier, have been reviewed recently (17, 28). 
Useful tools for testing the effector function of eosinophils include mice 
engineered to be deficient in major proteins stored in the secondary granules, MBP-1 
(29) or EPX (30).  Recently, Doyle et al. showed that mice bearing both deficiencies 
manifest a specific and near complete loss of peripheral and tissue eosinophils (31). 
This strain provides an additional ablation model with some advantages. Unlike the 
PHIL mouse, it does not express DT A chain, eliminating risk of damage to 
neighboring cells or tissues. In addition, the targeting effect in MBP-1-/-/EPX-/- mice 
appears to be highly specific for eosinophils, while ΔdblGATA mice have been 
reported to display mild anemia and impaired basophil function (32). Although the 
mechanisms underlying specific ablation of eosinophils in MBP-1-/-/EPX-/- mice are 
unclear, this new strain provides an additional tool for investigating eosinophil 
function in vivo.  
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Adoptive transfer of eosinophils to eosinophil-ablated mice is an experimental 
design that considerably expands the utility of the model. Applied widely and 
creatively in recent years, transfer of eosinophils isolated from IL-5Tg+ mice into 
eosinophil-ablated or other genetically deficient recipients allows for testing of the 
significance and temporal requirements for eosinophil-derived factors in vivo (33). 
The method can be elaborated upon, for example, by crossing IL-5Tg+ mice with 
MHCII-/- mice to test the significance of antigen presentation by eosinophils in 
immunity (34). Obviously, this variation on the method requires time consuming and 
costly breeding of the desired strains. Alternatively, bone marrow-derived eosinophils 
can be propagated for adoptive transfer experiments (35). This system provides a more 
rapid way to generate specific gene deficient eosinophils, although the number of cells 
produced may be limiting. 
A disadvantage of ablation models is that they do not enable contextual or 
temporal evaluation of eosinophil function in an otherwise eosinophil-replete animal. 
This challenge has been addressed by two groups, each using a knock-in strategy that 
inserted the gene for human DT receptor (DTR) into the EPX locus (36, 37). 
Depletion of eosinophils is induced by injection of DT. In the mouse model of asthma, 
inducible PHIL (iPHIL) mice were used to show that eosinophils were dispensable for 
sensitization to ovalbumin (OVA), although they were critical to the manifestation of 
disease following antigen challenge (36). These results document that the approach 
has value for time-limited depletion of eosinophils; however, complete depletion 
requires multiple DT treatments over a period of 14 days, a regimen that induces 
antibodies that prevent the toxin from reaching additional target cells. Thus, inducible 
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depletion is a useful tool for addressing the function of eosinophils during brief, but 
perhaps not prolonged intervals.  
Eosinophils display a variety of receptors, and produce an array of chemokines 
and cytokines that are known to be key regulators in different physiological and 
pathological processes (17, 18), yet it has been difficult to determine whether the 
eosinophil is the source of influential mediators in the mechanism under investigation. 
A mouse model that addresses this need is one in which a gene knock-out is targeted 
specifically to eosinophils. The newly created eoCRE mouse, in which Cre 
recombinase is expressed under the control of the EPX promoter, supports this 
approach (38). By crossing with a strain bearing a floxed gene, mice are generated that 
bear eosinophils that are deficient in the corresponding protein. The availability of this 
strain will be invaluable to documenting the significance of eosinophil-derived 
immunoregulatory mediators, such as IL-4, IL-13, or TGF-β in different disease 
models. Moreover, as mentioned by Rosenberg (39), eoCRE mice will enable an 
indirect assay of human eosinophil function via expression of human genes in mouse 
eosinophil. 
As with any experimental approach, caution must be applied in interpreting 
results from mouse studies of the sort described here, as different gene targeting 
strategies, depletion methods and transfer designs may create unique artifacts. The 
growing collection of mouse strains available for eosinophil manipulation provides an 
array of tools and approaches that will reduce this risk and significantly advance study 
of eosinophil function in vivo. The value of new mouse strains to research on 
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eosinophil function, and the generosity of spirit shown by their inventors in sharing 
such resources, must not go unrecognized.          
 
Functions of eosinophils revealed in mouse models 
Eosinophils and Th2 immunity 
Early histologic studies documented that eosinophils enter tissues during 
inflammation induced by helminth infection (40) or hypersensitivity (41). Release of 
pre-formed mediators and granule-stored proteins in such tissues is compatible with 
eosinophils serving as effector cells in Th2-driven immunity. In the context of 
parasitic disease, this function received further support from in vitro experiments that 
documented larval killing by eosinophils (14-16). More recently, as the diversity of 
receptors and soluble mediators produced by eosinophils has been revealed, their 
potential to regulate, as well as effect Th2 responses has been tested. 
Exposure to allergens and worm antigens induces eosinophils to upregulate 
surface MHCII and co-stimulatory molecules CD80, CD86 and CD40 (42, 43). 
Although murine eosinophils activate and present antigen to T cells in a variety of in 
vitro and in vivo experimental designs (34, 44, 45), antigen presentation has not yet 
been shown to impact the course of allergic disease in mice (33) or worm infection. In 
contrast, there is compelling evidence that eosinophils promote Th2 immunity by 
producing IL-4 following injection of schistosome eggs into mice (46) and by 
regulating recruitment and activation of dendritic cells (DC) and T cells (47-49). 
Accumulation of myeloid DCs in draining lymph nodes is eosinophil-dependent in 
allergic responses (33). Driven by eosinophil-derived IL-13, DCs and T cells work 
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cooperatively to restore allergic disease to eosinophil-ablated mice (48-50). These 
results are representative of broad, ongoing efforts to test the function of eosinophil-
derived molecules in health and disease, discussed further below.   
   
Eosinophils and tissue regeneration 
Recently, eosinophils have been linked to IL-4 driven regenerative responses 
to tissue injury (51, 52). Following cardiotoxin injection into skeletal muscle, 
eosinophils are dominant among IL-4-secreting cells that infiltrate the site, and the 
regenerative response is severely compromised in ΔdblGATA mice. Fibro/adipogenic 
progenitor cells (FAPs) at the site of injection are induced to express IL-4Rα. IL-4 
drives proliferation of FAPs, preventing their differentiation into adipocytes and 
supporting myogenic differentiation. Additional findings support the conclusion that 
FAPs promote muscle regeneration through their ability to phagocytose necrotic fibers 
(51). In the liver, infiltrating eosinophils are responsible for promoting IL-4-dependent 
regenerative responses to injury caused by CCl4 (52). Liver regeneration in this model 
is dependent, in part, on IL-4Rα expression on hepatocytes.  
These observations provide evidence that eosinophils contribute to tissue repair 
in two highly regenerative organs; however, direct evidence that the critical cytokine, 
IL-4 is derived from eosinophils is lacking, and other infiltrating cells also produce IL-
4 in injured tissues (51, 52). This question can be addressed definitively using 
eoCre/IL-4 mice or experiments in which IL-4 deficient eosinophils are transferred to 
injured, eosinophil-ablated mice (38).  
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Comparison of results from injury models with those from experiments with 
parasitic worms provides evidence that the response to injury varies, depending on 
both the insult and the tissue. For example, liver injury is a prominent feature of the 
granulomatous response to Schistosoma mansoni, yet eosinophils do not influence the 
development of granulomas in the livers of infected mice (53). Similarly, eosinophils 
do not play a role in protecting the liver against migrating Trichinella larvae (54, 55). 
In contrast, eosinophils play key roles in the response to muscle injury and infection 
by Trichinella (56, 57).   
 
Eosinophils and antibody responses 
Plasma cells in the bone marrow are the main source of circulating antibodies. 
The mediators and mechanisms responsible for the prolonged survival of these cells 
are crucial to sustaining a state of immunity. A variety of cell types populate niches 
that provide contact-dependent and secreted survival signals to plasma cells within the 
bone marrow. These include mesenchymal stromal cells (58), megakaryocytes (59), 
DCs (60, 61), macrophages (62), basophils (63) and eosinophils (64). Bone marrow 
eosinophils have been implicated as the main cellular source of the plasma cell 
survival factors, APRIL and IL-6 (64). Using adoptive transfer protocols in 
eosinophil-ablated recipient mice, it was shown that plasma cell survival is further 
enhanced when eosinophils are first activated with adjuvant (65), consistent with a 
role for eosinophils in plasma cell survival and antibody production in response to 
infection. Eosinophils are dispensable for the parasite-specific IgM response during 
primary infection by Strongyloides stercoralis (66). Nevertheless, antibodies are 
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protective against re-infection with some parasitic worms (67-70). Thus, experiments 
designed to assess the role of eosinophils in plasma cell survival, antibody production, 
and protective immunity in worm infections are warranted and relevant to devising 
new vaccine strategies.  
 
Eosinophils, obesity, and innate lymphoid type 2 cells 
IL-5 is a critical cytokine in regulating activity of eosinophils. Long known to 
be produced by conventional Type 2 lymphocytes and myeloid cells, recent reports 
show that lineage negative, innate lymphoid type 2 cells (ILC2) produce large 
quantities of IL-5 and IL-13 in response to the epithelial derived-cytokines IL-25 and 
IL-33. Two studies have demonstrated that the accumulation of eosinophils and 
alternatively activated macrophages (arginase-1 positive; AAMs) in mouse visceral 
adipose tissue (VAT) requires IL-5 and IL-13, respectively (71, 72), and ILC2s in 
VAT are the major source of these cytokines (71).  
IL-4 dependent AAMs in VAT are associated with metabolic syndrome, type 2 
diabetes, and insulin resistance. Eosinophils are the predominant source of local IL-4 
in VAT (72). The recruitment of IL-4-producing eosinophils to VAT by IL-5-
producing ILC2s further promotes alternative activation of adipose resident 
macrophages, which are required for increasing systemic insulin sensitivity. 
Administration of exogenous IL-33, or infection with Nippostrongylus brasiliensis, 
activates ILC2s to produce IL-5 and IL-13, promoting eosinophil and AAM 
accumulation in VAT as well as glucose tolerance (71). IL-33 is an alarmin that is 
released by injured cells (73). Thus, worm-induced injury may stimulate ILC2s to 
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recruit eosinophils that deliver IL-4 to local macrophages that are needed for glucose 
homeostasis during infection. 
IL-5 is constitutively produced by ILC2s in healthy tissues (74). In contrast, 
IL-13 production is induced in lung ILC2s by worm infection, leading to local CCL11 
production that promotes lung eosinophilia (74). Both lung and intestinal ILC2s 
express the functional receptors for a feeding-induced neuropeptide, vasoactive 
intestinal peptide (VIP), and increase the production of IL-5 in response to VIP 
stimulation. Thus, ILC2s respond to caloric intake by producing IL-5 and IL-13, 
thereby linking eosinophils to dietary cues. The response of eosinophils to food intake 
and their role in managing energy for the host, prompts speculation that they may 
influence the relationship of parasitic worms to their host’s metabolism in ways that 
support or compromise infection. 
 
Eosinophils in helminth infection 
Laboratory experiments in which larvae are killed by eosinophils in vitro, in 
the presence of antibody and/or complement, have informed the dogma that 
eosinophils protect the host against infection with parasitic worms (14-16). The 
mechanism of killing was confirmed when purified EPX was shown to be toxic for T. 
spiralis larvae (15). Subsequent work identified IL-5 as a critical growth factor for 
generation and expansion of eosinophils (8, 75), an advance that eventually yielded 
new tools to study the role of eosinophils in helminth infection, including IL-5 
neutralizing antibodies, IL-5 or IL-5 receptor knockout mice, and IL-5Tg+ mice 
(reviewed in Meeusen et al. (19) and Behm et al. (20)). Additional opportunities were 
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afforded by the identification and manipulation of the eotaxins and CCR3 (76). 
Studies of these molecules revealed important insights into their roles in directing 
eosinophil trafficking and expansion. Nevertheless, each of these regulatory mediators 
or receptors has multiple cellular targets (77, 78) and most importantly, their 
deficiency or depletion does not completely eliminate eosinophils from the body. 
Therefore, if a deficient mouse mounts a WT response, it is difficult to eliminate 
eosinophils as contributors to the mechanism under study. 
Several helminth infections have been tested in mouse models of eosinophil 
ablation.  The aggregated data reveal a marked disparity in eosinophil function among 
worms that colonize intestinal versus extra-intestinal sites. In PHIL and ΔdblGATA 
mice infected with S. mansoni, there are no obvious defects in immune responses, 
worm burdens, or egg deposition (53). Furthermore, egg-induced liver lesions, 
including granuloma formation and fibrosis, are not affected by eosinophil ablation 
(53). Larvae survival and development of primary and secondary immune responses 
are normal in PHIL mice infected with S. stercoralis (66). Similarly, eosinophils are 
dispensable for the development of intestinal Th2 responses to Trichuris muris and 
worm expulsion is normal in ΔdblGATA mice (79). Immune responses induced by 
primary infection with the murine hookworm, N. brasiliensis, are only marginally 
affected in ΔdblGATA mice (80). Infection of either PHIL or ΔdblGATA mice with 
T. spiralis showed that eosinophils are dispensable for intestinal immunity that clears 
adult worms (57).  Mechanisms of immunity across these five infections vary 
considerably, and the negative results indicate that eosinophils are broadly ineffective 
in intestinal immunity mounted against primary worm infections. 
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Although intestinal Trichinella are not influenced by eosinophils, the outcome 
of muscle infection in either primary or secondary infections is profoundly altered in 
PHIL and ΔdblGATA mice. These findings are discussed in detail in the next section. 
Additional evidence that eosinophils are influential in extra-intestinal tissues was 
revealed by infection of eosinophil-ablated mice with the filarial nematode, 
Litomosoides sigmodontis. Growth of adult L. sigmodontis is impaired in the absence 
of eosinophils or IL-5, providing further support for the hypothesis that some 
helminths depend upon eosinophil-rich microenvironments (81). 
 
Eosinophils and Trichinella infection 
Among parasitic worms, Trichinella is unusual in that it completes its life 
cycle in a single animal host. Furthermore, growth and development of all life-stages 
occurs intracellularly. The infection occurs in two phases. First-stage larvae are 
ingested and develop into adult worms in the intestine, where they reproduce. 
Newborn larvae (NBL) migrate from the intestine to skeletal muscles, where they 
invade myotubes, grow rapidly, and establish chronic, intracellular infection (Fig. 
1.1). Eosinophilia is prominent during both phases of infection; however, eosinophils 
do not contribute to intestinal immunity that expels worms from the gut or limits their 
fecundity (57, 82), nor do they influence liver injury caused NBL as they migrate from 
the intestine (54, 55). In stark contrast, eosinophils have a profound effect on the 
growth and survival of intracellular larvae in skeletal muscle. We have reported that in 
either ΔdblGATA or PHIL mice, larval burdens in skeletal muscle are significantly 
reduced (56, 57). Poor larval survival correlates with reduced infiltration of infected 
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Figure 1.1. The T. spiralis nurse cell. Formalin-fixed, paraffin-embedded tongue 
from a C57BL/6 mice at 28 dpi was stained with hematoxylin and eosin. Features of 
the nurse cell are indicated. Arrow indicates eosinophil and arrowhead indicates 
muscle larva. Scale bar = 50 µm. 
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muscle by Th2 cells, in association with expanded local production of nitric oxide 
(NO) (56). NO is toxic for growing larvae (56). Among leukocytes that infiltrate 
infected muscle, IL-10 from CD4+CD25- T cells suppresses IFN-γ production and 
induction of iNOS in macrophages and neutrophils (83). Moreover, larval burdens are 
reduced in IL-10 deficient mice (57, 83, 84) confirming a central role for IL-10 in 
promoting survival of intracellular larvae. In the absence of eosinophils, IL-10+CD4+ 
T cells are reduced, implicating eosinophils as drivers of the IL-10 response (56). 
Ongoing research in our lab has shown that, by producing IL-10 at the initiation of 
muscle infection, eosinophils expand IL-10-producing myeloid DCs and CD4+ T cells 
which in turn inhibit the production of local NO and protect muscle larvae. Indeed, 
transfer of IL-10 competent DCs or CD4+ T cells compensates for eosinophil 
deficiency (85). These findings are consistent with an earlier report that eosinophils 
were required for DC recruitment and accumulation in lung draining lymph nodes in 
the allergy model (33). Unsolved questions include the mechanism of DC recruitment 
by eosinophils and, most importantly, the trigger that induces eosinophils to make IL-
10.  
Following invasion of skeletal muscle cells, intracellular larvae undergo a 
period of rapid growth over the course of 20 days. Larvae grow poorly in muscles of 
eosinophil-ablated mice, an effect that is not dependent on local NO and is separable 
from immune-mediated killing (56). Results of pilot studies indicate that eosinophil-
derived IL-4, but not IL-10, is critical for supporting larval growth (86). Although it is 
not known how eosinophil-derived IL-4 may support larval growth, it is intriguing to 
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consider that the parasite may be exploiting the IL-4 dependent regenerative response 
of muscle that would follow injury caused by invading larvae. Alternatively, the 
influence of eosinophil-derived IL-4 on glucose metabolism in adipose tissues may be 
relevant to infected muscle cells that require a source of energy for growing larvae. 
Currently, we are exploring these mechanisms.   
During secondary worm infection, the functions of eosinophils appear to 
switch from immunoregulation to immune defense. Eosinophils have been 
demonstrated to be important for protective responses in secondary subcutaneous 
larval infection with N. brasiliensis, as revealed by the increased numbers of larvae 
migrating to the lungs in IL-5-/- and ΔdblGATA mice (80).  Similarly, muscle burdens 
are increased in ΔdblGATA mice upon secondary infection with T. spiralis. Similar to 
N. brasiliensis, migration of T. spiralis NBL is increased in ablated versus WT mice 
(87). The results are compatible with earlier reports that eosinophils attach to T. 
spiralis NBL via specific antibodies and kill by releasing eosinophil peroxidase (EPX) 
(15). Confirmation of this mechanism requires experiments in which protection can be 
conferred upon naïve ΔdblGATA mice by transferring sera from infected mice 
together with eosinophils. Neither EPX nor MBP-1 is influential in primary infection 
(56); however re-infection of the knockout strains has not yet been performed. In 
summary, observations from mice infected with N. brasiliensis and T. spiralis are 
consistent with a mechanism in which antibodies compromise the rapid movement of 
larvae in tissue, enabling binding and killing by eosinophils. Further experimentation 
is required to confirm this hypothesis.  
 18 
Collectively, the unexpected roles of eosinophils in T. spiralis infection 
provide new insights into the functions of this enigmatic cell. During primary 
infection, eosinophils manipulate host immune responses in ways that create a more 
favorable environment for the parasite. In secondary infection, eosinophils protect 
muscles against invading larvae, preventing accumulation of additional parasite 
burdens and thereby prolonging survival of both the host and the parasites already 
established in the muscle (Fig. 1.2). 
 
Conclusion 
Recent advances in eosinophil ablation and creation of new tools have 
advanced our understanding of what eosinophils do during helminth infection. It is 
surprising that eosinophils appear to be dispensable for intestinal immunity against 
worms. Data from studies of tissue-dwelling worms provide evidence that eosinophils 
may be influential in the delivery of essential host resources to the parasite. With 
further expansion of the toolset, the roles of the eosinophil at the intersections among 
immunity, injury, and parasitism will be revealed. New knowledge will enhance 
efforts to develop novel treatments and vaccination strategies for parasitic diseases. 
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Figure 1.2. Functional versatility of eosinophils in Trichinella infection. In primary 
infection, Trichinella induces a mixed Th1 and Th2 immune response associated with 
eosinophilia in skeletal muscle. By secreting IL-10, eosinophils promote the expansion 
of IL-10 producing myeloid DCs, and enhance the production of IL-10 by CD4+CD25- 
T cells. The production of NO by IFN-γ activated iNOS+ macrophages and neutrophils 
is suppressed by IL-10, thereby promoting survival of muscle larvae. Through a 
different but poorly understood mechanism, eosinophils and IL-4 support larval 
growth in skeletal muscle. In secondary infection, Trichinella-specific antibodies 
promote adhesion and activate eosinophils to release granule proteins that destroy 
migrating NBL.  
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Abstract  
Eosinophilia is a feature of the host immune response that distinguishes 
parasitic worms from other pathogens, yet a discrete function for eosinophils in worm 
infection has been elusive. The aim of this study was to clarify the mechanism(s) 
underlying the striking and unexpected observation that eosinophils protect 
intracellular, muscle-stage Trichinella spiralis larvae against NO-mediated killing. 
Our findings indicate that rapid, specific recruitment of eosinophils to sites of 
infection at the earliest stage of muscle infection, consistent with a local response to 
injury, is essential for larval survival. By producing IL-10 at the initiation of infection, 
eosinophils expand IL-10+ myeloid dendritic cells and CD4+ IL-10+ T lymphocytes 
that inhibit iNOS expression and protect intracellular larvae. The results document a 
novel immunoregulatory function of eosinophils in helminth infection, in which 
eosinophil-derived IL-10 drives immune responses that eventually limit local NO 
production. In this way, the parasite co-opts an immune response in a way that 
enhances its own survival. 
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Introduction 
Eosinophilia is a prominent consequence of Th2 immunity mounted in 
response to infections by parasitic helminths. Cytotoxic effects of eosinophils, 
mediated by cationic granule proteins, have been considered to be their central 
influence in worm infections (1, 2). Recent investigations of the roles of eosinophils in 
health and disease have provided new insights into the versatility of this cell 
population. In mouse models, eosinophils influence insulin resistance (3, 4), promote 
the regenerative response to toxic injury of skeletal muscle (5) and liver (6), and are 
required for recruitment of Th2 cells to the lung in allergy (7-9). Eosinophils 
constitutively express IL-4 (10) and production of IL-4 or IL-13 is key to the role of 
eosinophils in each of these contexts. Eosinophils also regulate adaptive immunity by 
producing cytokines (11), and this property has been tested in experiments that are 
relevant to the outcome of worm infection. In one example, eosinophils serve as an 
early source of IL-4, promoting Th2 cell polarization when Schistosoma mansoni eggs 
are injected into peritoneal cavities of mice (12). Moreover, eosinophils express 
MHCII and costimulatory molecules CD80 and CD86 on the cell surface and are 
capable of presenting allergens and helminth antigens to T cells (13-15). Perhaps 
equally likely is the potential for eosinophils to promote maturation of dendritic cells 
(DCs) in order to enhance antigen-specific Th2 immune responses (16, 17). While 
these studies provide evidence for immunoregulatory function of eosinophils in worm-
induced Th2 immunity, the significance of antigen presentation or IL-4 secretion have 
yet to be confirmed in the course of an infection. 
 32 
Despite their prominence in the response to infection by intestine-dwelling 
parasitic worms, including Trichinella spiralis, findings from experiments in 
eosinophil ablated strains of mice consistently indicate that eosinophils do not 
contribute in a discernable way to intestinal immunity (18-20). In contrast, eosinophils 
promote the growth and survival of T. spiralis larvae as they colonize skeletal muscle 
(20, 21). In two strains of mice in which the eosinophil lineage has been ablated (PHIL 
and ΔdblGATA) (22, 23), growing larvae in muscle are killed by a nitric oxide (NO)-
dependent mechanism (21). Providing mice with eosinophils during the first 10 days 
of muscle infection prevents killing (21) suggesting that eosinophils may directly 
regulate inducible nitric oxide synthase (iNOS) expression by local macrophages and 
neutrophils. Other findings document that expression of iNOS in leukocytes that 
infiltrate sites of infection is regulated, in part, by CD4+ T cells that produce IL-10 
(24, 25).  The relationship between eosinophils and CD4+IL-10+ T cells has not yet 
been elucidated. 
In the studies reported here, we aimed to elucidate the specific activity of 
eosinophils that regulates local NO production. We found that eosinophils are rapidly 
and specifically recruited to sites of infection and that the presence of eosinophils at 
the earliest stage of muscle infection is necessary for larval survival four weeks later. 
Neither antigen presentation nor production of IL-4 by eosinophils is essential for 
preserving the parasite. In contrast, by producing IL-10, eosinophils expand IL-10+ 
myeloid DCs and CD4+IL-10+ T cell that suppress local NO production and thus 
preserve larvae in muscle. Our results provide evidence that a parasitic worm co-opts 
the regulatory capacity of eosinophils in a way that supports its own survival.  
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Materials and Methods 
 
Rats and mice 
Adult Albino Oxford strain rats were produced and maintained in the Baker 
Institute vivarium. ΔdblGATA, PHIL, VertX, Rag1-/-, IL-5-expressing transgenic 
(NJ.1638) (IL-5Tg+), IL-5Tg+/MHCII-/-, IL-5Tg+/IL-4-/- mice were bred at Cornell 
Transgenic Mouse Core Facility and offspring were transferred to the Baker Institute. 
IL-10-/- mice were purchased from The Jackson Laboratory. Rag2-/-γc-/- mice were 
purchased from Taconic. Arg1flox/flox;Tie2cre mice were a gift from Dr. Thomas Wynn 
(NIAID). PHIL mice were genotyped as described previously (22). All strains were on 
a C57BL/6 background. C57BL/6 NHsd mice were purchased from Taconic as wild 
type (WT) controls. Animal care was in accordance with the guidelines of the 
Association for Assessment and Accreditation of Laboratory Animal Care and 
experiments were performed with the approval of the Institutional Animal Care and 
Use Committee of Cornell University. 
 
Parasite and Antigens 
Trichinella spiralis first-stage larvae (L1) and newborn larvae (NBL) were 
recovered from rats as described previously (20). For oral infection, L1 were 
suspended in 2% nutrient broth (Difco), 0.6% gelatin (Fisher Scientific) and doses of 
300 L1 were administered by gavage. For synchronous infection, 25,000 NBL were 
suspended in 0.25 ml serum-free DMDM (Mediatech, Inc.) and delivered by retro-
orbital injection. Mice were euthanized by CO2 inhalation at the times indicated in 
each experiment. Whole body muscle larvae burdens were assessed in whole carcasses 
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28 days postinfection (dpi) as described previously (20). In some experiments, larvae 
were recovered from diaphragms 17 dpi by digesting minced tissue for 15 min at 37 
°C in 5 mg/ml collagenase I (Sigma), a method that allows recovery of larvae and 
leukocytes, enabling evaluation of the cellular response at a time that is relevant to 
larval survival. Crude somatic antigens from L1 were prepared as previously described 
(20).  
 
Eosinophil transfer experiments 
Eosinophils were recovered from infected or uninfected IL-5Tg+, IL-
5Tg+/MHCII-/-, IL-5Tg+/IL-4-/- or infected IL-10-/- mice 12-20 dpi. Cells were pooled 
from spleens and peritoneal lavage fluid and purified by magnetic bead selection as 
previously described (21). Briefly, eosinophils were labeled with PE-conjugated anti-
Siglec-F antibody (BD) and anti-PE microbeads (Miltenyi Biotec). Average purity of 
eosinophils from this procedure was >93%. After washing twice with PBS, 5 × 106 
eosinophils were resuspended in 200 µl sterile PBS and injected i.v. into ΔdblGATA 
mice every 48 h for 6 days. 
 
Cell isolation from lymph node for DC phenotyping 
Cells from cervical lymph nodes (dLNs) for DC phenotyping were isolated as 
described previously (35). Briefly, dLNs were digested at 37 °C on a shaker for 15 
min with 1.75 Wunsch Units/ml Liberase CI (Roche) and 80 Units/ml DNase I 
(Sigma) in Hanks buffered saline (Cellgro) containing 1mM MgCl2, 1.8mM CaCl2, 50 
U/ml penicillin and 50 µg/ml streptomycin (Gibco). 100 µl 0.1M EDTA (pH 7.3) per 
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milliliter was then added to stop the reaction, and the tube was immediately diluted to 
15 ml with DMEM containing 50 U/ml penicillin and 50 µg/ml streptomycin. 
Undigested tissue was manually dispersed on a stainless steel tea strainer, using 12 ml 
syringe pestle. Cell preparations were passed through 70 µm filters into a 50 ml tube 
to obtain a single-cell suspension. Cells were washed with PBS containing 2% FCS 
and analyzed by flow cytometry for DC phenotyping as described below.  
 
CD4+ T cell isolation 
CD4+ T cells were recovered from dLNs of infected WT and IL-10-/- donor 
mice on 17 dpi and enriched by negative selection on magnetic beads using CD4 T 
Cell Isolation Kit II (Miltenyi Biotec). Average purity was 94%. 3-5 × 106 CD4+ T 
cells were suspended in PBS and injected i.v. into ΔdblGATA recipients that had been 
infected with 300 L1 4 days previously.  
 
Culture of bone marrow-derived dendritic cells (BMDCs) 
BMDCs were generated as described previously (69). Briefly, bone marrow 
cells were isolated from naïve WT and IL-10-/- donor mice. Cells were plated (5 × 
105/ml) in complete RPMI medium in the presence of recombinant murine GM-CSF 
(20 ng/ml; Peprotech) for 3 days. Fresh medium containing GM-CSF (20 ng/ml) was 
added to cultures on 3 and 6 days. On day 9, non-adherent cells were harvested and 
stained for CD11c, MHCII and CD11b to evaluate the purity (>90%) by flow 
cytometry. BMDCs were then primed with 50 µg/ml L1 crude somatic antigen for 18 
h. Primed cells were washed in PBS, suspended in PBS, and 5 × 106 BMDCs were 
 36 
injected i.v. into ΔdblGATA mice that had been infected with 300 L1 4 days 
previously.  
 
Flow cytometry 
Cells from individual diaphragms were recovered following perfusion of blood 
from tissues, as described previously (21), and cultured ex vivo for 6 h with 250 ng/ml 
ionomycin (Sigma-Aldrich), 50 ng/ml PMA (Sigma-Aldrich), and 1 µg/ml brefeldin A 
(BD Pharmingen). After a 15 min incubation with Fc block (eBioscience) and 10% 
normal mouse serum, cells were incubated for 15 min with PE-Cy5-conjugated anti-
CD4 (eBioscience). Samples were then treated with fixation/permeabilization buffer 
(eBioscience), and permeabilized cells were incubated for 1 h with PE-conjugated 
anti-IL-4 (eBioscience) or anti-IL-10 (eBioscience).  
For dendritic cell phenotyping, cells from dLNs and diaphragms were incubated 
FITC-conjugated anti-CD11b, PE-conjugated anti-CD11c and Pacific blue-conjugated 
anti-MHCII. Data were acquired using a Gallios flow cytometer (Beckman Coulter) 
and analyzed with FlowJo software (Tree Star) 
 
Parasite measurement 
Body area was measured as described previously (21). Briefly, developing L1 
larvae were recovered (17 dpi) by digesting minced diaphragms for 15 min at 37 °C in 
PBS containing 2% FCS and 5 mg/ml collagenase I (Sigma). Larvae were treated with 
70% ethanol (warm up at 56 °C) overnight. Larvae were then centrifuged and 
resuspended in 5% glycerol/70% ethanol for one day and then transferred to slides 
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using a Cytospin. Slides were fixed with methanol and stained with HEMA-3 (Fisher 
Healthcare), and measurements were performed using a BX51 microscope. The area 
of each larva was calculated by Microsuite Basic Olympus software. At least 25 larvae 
were measured per mouse, and values are expressed in µm2.  
 
Multiplexed cytokine assay 
Cytokines were measured in serum using the Bio-Plex 200 multiplex system 
(Bio-Rad) and the Bio-Plex Pro TM mouse cytokine 23-plex Assay kit (M60-
009RDPD), following manufacturer’s instructions. 
 
Quantitative RT-PCR 
Total RNA was isolated from masseter tissue using TRIzol reagent 
(Invitrogen). Reverse transcription of the RNA (1 µg) was performed using 
SuperScript III First-Strand Synthesis System (Invitrogen). Quantitative RT-PCR 
(qRT-PCR) was performed using the Applied Biosystems PRISM 7500 Sequence 
Detection System and its analysis software, SDS 2.3 and RQ Manager. The reactions 
were performed using the Taqman Universal PCR Master Mix. All primers were 
purchased from Applied Biosystems.  
 
Statistical analysis 
All experiments were performed twice with similar results. Means ± SD were 
calculated from data collected from individual mice unless otherwise indicated. 
Significant differences were determined using Student’s t test or one-way ANOVA 
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with Tukey’s post hoc test for multiple means. Statistical analysis was performed with 
GraphPad Prism 5 software.  
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Results 
Arginase 1 is required for the suppression of NO-mediated larval clearance but 
does not support larval growth 
Infective first-stage larvae of T. spiralis colonize the intestine, develop into 
adult worms, and release migratory newborn larvae (NBL) that eventually enter 
skeletal muscle, invade myotubes, grow rapidly, and establish chronic, intracellular 
infection. Diaphragm and masseter are preferred muscles for infection in mice and the 
life cycle is complete in 28 days. At this time, first-stage larvae in muscle are fully 
infectious. In the absence of eosinophils, larval growth is impaired and larval survival 
is reduced (20, 21).   
We have reported previously that Arginase 1 (Arg1) expression is decreased in 
skeletal muscles of eosinophil-ablated mice at 17 dpi (21) and that infiltrating 
neutrophils and macrophages were iNOS+ in WT mice. With the knowledge that Arg1 
competes with iNOS in controlling the production of NO, and that NO is toxic for 
growing T. spiralis larvae (21), we aimed to test larval clearance in mice deficient in 
Arg1. Compared with WT mice, larval burdens were reduced in Arg1flox/flox;Tie2cre 
mice (Fig. 2.1. A), although larvae grew normally (Fig. 2.1. B). The reduction in 
muscle burden was associated with enhanced NO production in antigen stimulated 
draining lymph node (dLN) cell cultures (Fig. 2.1. C). These results, together with 
those obtained previously (20, 21) support a role for NO producing myeloid cells in  
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Figure 2.1. Arg1 is required for larval survival but not growth. (A) Larval burdens 
in muscle of Arg1flox/flox;Tie2cre and Arg1flox/flox mice, 26 dpi. (B) Body size (area) of 
larvae recovered from infected Arg1flox/flox;Tie2cre and Arg1flox/flox mice, 17 dpi. Bars 
represent means from at least 75 larvae pooled from masseters of 3 mice. (C) NO 
production in antigen-stimulated dLN cell cultures. Each data set was collected from 
two experiments with similar results. Values represent mean ± SD; n = 3 - 4 mice. 
Significant differences were determined by Student’s t test or ANOVA and Tukey’s 
test. *p < 0.05 
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larval clearance. Importantly, this toxicity is separable from the compromise of larval 
growth that also occurs in eosinophil-ablated mice. 
 
IL-10 derived from CD4+ T cells compensates for eosinophil deficiency 
We have shown previously that NO production in infected muscles of IL-10-
deficient mice was reduced by adoptive transfer of IL-10-competent CD4+ T cells 
(24). By testing the impact of eosinophil-ablation on CD4+ T cells at sites of infection, 
we found that reduced larval survival correlated with impaired recruitment of CD4+IL-
10+, as well as CD4+IL-4+ T cells, to sites of infection (compare WT to PBS treated 
eosinophil-ablated mice in Fig. 2.2. A - C). When CD4+ T cells from dLN of WT 
infected mice were transferred to ΔdblGATA mice, they infiltrated skeletal muscle 
and promoted leukocyte infiltration (data not shown), documenting that the local 
environment in ablated mice was not deficient in chemoattractants or endothelial cell 
surface molecules necessary for T cell and leukocyte recruitment. Indeed, local gene 
expression of chemokines that recruit Th2 cells was unaltered in ablated mice (Fig. 
2.2. D). Furthermore, expression of markers of T cell activation was similar in cells 
recovered from diaphragms of T. spiralis-infected WT, PHIL or ΔdblGATA mice 
(Fig. 2.2. E and F). Thus, the local environment was compatible with CD4+ T cell 
recruitment and CD4+ T cells were being activated, but they were compromised in 
their abilities to produce IL-4 and IL-10. Transfer of CD4+ T cells from infected WT 
donors to eosinophil-ablated mice (4 dpi) improved larval burdens and promoted 
infiltration of CD4+IL-10+ cells (Fig. 2.2. A and B). In contrast, transfer of CD4+ T  
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Figure 2.2. IL-10 derived from CD4+ T cells protects larvae in muscle. (A) – (C), 5 
× 106 CD4+ T cells from infected WT or IL-10-/- mice were transferred to ΔdblGATA 
recipient mice on 4 dpi. (A) Larval burdens in diaphragms, 17 dpi. (B) Number of 
CD4+IL-10+ cells and (C) CD4+IL-4+ cells in diaphragms of mice, 17 dpi. (D) qPCR 
analysis of IL-13, CCL11, CCL17 and CCL22 in masseter muscles of WT, PHIL, 
ΔdblGATA mice, 14 dpi. (E) Percentage and (F) MFI of CD11a+, CD18+ and CD69+ 
on gated CD4+ T cells recovered from dLNs of WT and ΔdblGATA mice, 14 dpi. A – 
F, Each data set was collected from two experiments with similar results. Values 
represent mean ± SD; n = 3 - 4 mice. Significant differences were determined by 
Student’s t test or ANOVA and Tukey’s test. *p < 0.05, **p < 0.001, ***p < 0.0001. 
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cells from infected IL-10-/- donors had neither effect (Fig.  2.2 A and B). CD4+IL-4+ 
cells were recruited independently of the IL-10 status of donor cells (Fig. 2.2. C). 
Thus, CD4+IL-10+ T cells were capable of compensating for the absence of 
eosinophils in controlling local NO production, supporting the conclusion that the 
direct action of eosinophils on NO-producing leukocytes was not required to protect 
larvae from killing. 
 
Eosinophils promote accumulation of IL-10+ myeloid DCs and IL-10-producing 
DCs compensate for eosinophil deficiency 
The finding that eosinophils impact production of CD4+IL-10+ T cells, together 
with the knowledge that eosinophils influence DCs in allergy (16), prompted us to test 
the impact of eosinophil-ablation on DCs in T. spiralis infection. Quantification of 
CD11c+ cells in dLNs of infected WT, PHIL and ΔdblGATA mice revealed no 
differences on 7, 9 and 11 days of infection (data not shown); however, fewer 
CD11c+CD11b+MHCIIhigh cells were recovered from dLN and diaphragm on day 11 in 
eosinophil-ablated mice (Fig. 2.3. A - C). The results are consistent with earlier 
findings that eosinophils were required for DC trafficking and accumulation in lung 
dLNs following aeroallergen provocation (26). Indeed, accumulation of 
CD11c+CD11b+MHCIIhigh cells (myeloid DCs, mDCs) in T. spiralis-infected 
diaphragm significantly improved when eosinophils were restored to ΔdblGATA mice 
(Fig. 2.3. C), confirming that recruitment or expansion of mDCs was dependent upon 
eosinophils. Moreover, the percentage of diaphragm mDCs that were IL-10+ was  
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Figure 2.3. Eosinophils promote accumulation of IL-10+ mDC that protect larvae. 
(A) Percentage of CD11b+CD11c+MHCII+ mDCs in total CD11c+ cells in dLN 7, 9 
and 11 dpi. (B) Percentage of mDC of total diaphragm cells, 11 dpi. (C) Numbers of 
mDC cells recovered from diaphragms of ΔdblGATA mice (11 dpi) that received 5 × 
106 eosinophils or PBS on alternate days from 5 – 9 dpi. (D) Percentage of total 
diaphragm cells that were IL-10+ mDCs, 11 dpi. (E) – (G), ΔdblGATA mice received 
5 × 106 antigen-primed BMDCs from WT or IL-10-/- mice, 4 dpi. (E) Larval burdens 
in diaphragms, 17 dpi. (F) Number of CD4+IL-10+ cells and (G) CD4+IL-4+ cells in 
diaphragms, 17 dpi. Each data set was collected from two experiments with similar 
results. Values represent mean ± SD; n = 3 - 4 mice. Significant differences were 
determined by Student’s t test or ANOVA and Tukey’s test. *p < 0.05, **p < 0.001, 
***p < 0.0001. 
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reduced in eosinophil-ablated mice (Fig. 2.3. D). Bone marrow-derived DCs (BMDC) 
that were incubated with larval antigens prior to transfer to ΔdblGATA mice on 4 dpi 
increased survival of larvae (Fig. 2.3. E) and improved recruitment of CD4+IL-4+ and 
CD4+IL-10+ T cells to diaphragms (Fig. 2.3. F and G).  In contrast, transfer of larval 
antigen primed BMDC from IL-10-/- donors only improved the number of CD4+IL-4+ 
T cells in diaphragm without affecting either CD4+IL-10+ T cells or larval survival 
(Fig. 2.3. E - G). Thus, eosinophils both recruit mDCs and support their production of 
IL-10. Such cells likely drive expansion of CD4+IL-10+ cells that limit iNOS 
expression (24) and NO-mediated larval killing. 
 
Eosinophils arrive and exert their influence immediately following muscle 
infection  
To further investigate the function of eosinophils, we sought to determine the 
time at which eosinophils normally extravascate at sites of skeletal muscle infection. 
In order to synchronize infection of the muscle, we injected NBL intravenously into 
WT mice. Eosinophil numbers increased dramatically in the diaphragm between 6 and 
12 h following injection (Fig. 2.4. A). This was preceded by increases in serum IL-5, 
RANTES and KC (Fig. 2.4. B), three important drivers of eosinophil chemotaxis. IL-6 
in serum also increased upon injection (Fig. 2.4. B). Results for other mediators in the 
panel were not significant. Neutrophils did not extravascate in diaphragm until 12-24 h 
following injection (Fig. 2.4. A), documenting a strong  
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Figure 2.4. Eosinophils are rapidly and specifically recruited to muscle to 
promote larval survival during infection. (A) Numbers of eosinophils (Siglec-F+ 
cells) and neutrophils (Ly-6G+ (clone 1A8) cells) in diaphragms of naïve or WT mice, 
6, 12, 24 and 48 h post injection with 25,000 NBL. (B) Concentrations of IL-5, KC, 
RANTES and IL-6 in sera from mice in (A). (C) Larval burdens in diaphragms, 17 
dpi, of ΔdblGATA mice that received 5x106 eosinophils or PBS every 48 h between 5 
– 9 dpi or 11 – 15 dpi (oral infection). Each data set was collected from two 
experiments with similar results. Values represent mean ± SD; n = 3 - 4 mice. 
Significant differences were determined by Student’s t test or ANOVA and Tukey’s 
test. *p < 0.05, **p < 0.001, ***p < 0.0001.  
 
 47 
selection for eosinophils in the early recruitment of leukocytes to infected tissue (the 
ratio of neutrophils to eosinophils in the blood is approximately 25:1). Transfer of 
eosinophils collected from IL-5Tg+ mice to ΔdblGATA mice during two different 
intervals confirmed that larval survival was dependent upon the presence of 
eosinophils between day 5 and 9 following oral infection, a period during which NBL 
first arrive in muscle (Fig. 2.4. C). Transfer of similar numbers of eosinophils between 
days 11 and 15 had a modest but not statistically significant effect on larval survival. 
Experimental outcomes were similar when eosinophil donors were either uninfected or 
infected (data not shown). Taken together, the results support the conclusion that rapid 
recruitment of eosinophils to sites of infection positions them to influence the 
initiation of the immune response.  
 
Type 2 innate lymphoid cells are not required to promote muscle eosinophilia 
and larval survival  
The newly discovered type 2 innate lymphoid cells (ILC2) have been 
demonstrated to recruit eosinophils by releasing preformed IL-5 (3, 27). In order to 
determine whether ILC2 influence recruitment of eosinophils to sites of infection, as 
well as larval survival, we injected NBL into ILC-ablated Rag2-/-γc-/- mice. 
Intravenous infection controls the dose of NBL that are delivered to the muscle by 
circumventing the prolonged survival of fecund intestinal worms that occurs in 
lymphocyte-deficient mice.  Although there were fewer eosinophils in the spleens in 
Rag2-/-γc-/- compared to Rag1-/- mice (Fig. 2.5. A), the recruitment of eosinophils to  
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Figure 2.5. ILC2 are dispensable for muscle eosinophilia and larval survival. (A) 
– (C), Rag1-/- and Rag2-/-γc-/- mice were injected 25,000 NBL intravenously. Numbers 
of eosinophils in (A) spleens and (B) diaphragms, 13 dpi. (C) Total body larval 
burdens in muscle, 24 dpi. Each data set was collected from two experiments with 
similar results. Values represent mean ± SD; n = 4 mice. Significant differences were 
determined by Student’s t test. ***p < 0.0001. 
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sites of infection was normal in the absence of ILC2 (Fig. 2.5. B). More importantly, 
larval burdens were equal in both strains of mice (Fig. 2.5. C). Taken together, the 
results indicate that muscle eosinophilia and larval survival are not dependent on 
ILC2.  
 
Antigen presentation by eosinophils is not required to preserve larvae 
The requirement for eosinophils during the earliest phase of the IL-10-
dependent immune response suggested that, in addition to promoting IL-10 production 
by mDCs (Fig. 2.3. D), eosinophils may themselves present antigen. To better 
understand whether larval survival is a consequence of MHCII-dependent antigen 
presentation by eosinophils, we transferred MHCII-/- eosinophils isolated from 
infected IL-5Tg+/MHCII-/- mice to infected ΔdblGATA mice (5 - 9 dpi). Both 
MHCII+/+ AND MHCII-/- eosinophils supported larval burdens, larval growth (Fig. 2.6 
A and B), and accumulation of CD4+IL-4+ cells in diaphragm (Fig. 2.6. C). Thus, 
antigen presentation by eosinophils is not required to promote larval survival or to 
drive Th2 responses.  
 
Eosinophil-derived IL-10, but not IL-4 is required for larval survival 
We next examined whether eosinophil-derived IL-4 promotes larval survival in 
skeletal muscle. Transfer of IL-4-/- eosinophils isolated from IL-5Tg+/IL-4-/- mice to 
infected ΔdblGATA mice improved larval burdens and this correlated with an increase 
in the number of CD4+IL-10+ cells in diaphragms (Fig. 2.7. A and B) but not CD4+IL- 
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Figure 2.6. Antigen presentation by eosinophils is not required to preserve larvae. 
(A) – (C), ΔdblGATA mice received PBS or 5 × 106 eosinophils from infected IL-
5Tg+ or IL-5Tg+/MHCII-/- mice every 48 h from 5 – 9 dpi. (A) Larval burdens in 
diaphragms, 17 dpi. (B) Body size (area) of larvae, 17 dpi. (C) Numbers of CD4+IL-4+ 
cells in diaphragms, 17 dpi. Each data set was collected from two experiments with 
similar results. Values represent mean ± SD; n = 4 mice. Significant differences were 
determined by ANOVA and Tukey’s test. *p < 0.05, **p < 0.001, ***p < 0.0001. 
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4+ T cells (Fig. 2.7. C). In other experiments, IL-13-/- and WT mice responded 
similarly to infection with T. spiralis (data not shown). The results support the 
conclusions that both IL-4 and IL-13 are dispensable in eosinophil-mediated 
regulation of immunity that preserves T. spiralis larvae by preventing local production 
of NO. We detected eosinophils producing IL-10 in infected reporter mice (VertX 
strain (28)) confirming that eosinophils in dLN and diaphragms expressed the gene 
(Fig. 2.7. D). Furthermore, transfer of eosinophils from IL-10-/- mice to ΔdblGATA 
recipients failed to improve burdens (Fig. 2.7. E), while IL-10 competent eosinophils 
rescued larvae and enhanced recruitment of CD4+IL-10+, but not CD4+IL-4+ T cells to 
sites of infection (Fig. 2.7. E - G). Thus, the mechanism of action of eosinophils in 
preserving larvae in muscles depended upon intrinsic production of IL-10 that directed 
the adaptive immune response via IL-10+ mDCs and CD4+IL-10+ T cells, ultimately 
inhibiting expression of iNOS and preventing NO-mediated killing of the parasite. 
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Figure 2.7. Eosinophil derived IL-10 preserves larvae. (A) – (C), ΔdblGATA mice 
received PBS or 5 × 106 eosinophils from infected IL-5Tg+ or IL-5Tg+/IL-4-/- mice 
every 48 h from 5 – 9 dpi. (A) Total body larval burdens in muscle, 28 dpi. (B) 
Number of CD4+IL-10+ cells and (C) CD4+IL-4+ cells in diaphragms of mice, 17 dpi. 
(D) IL-10 detected in eosinophils recovered from dLNs and diaphragms of infected 
Vertx mice, 13 dpi. (E) – (G), ΔdblGATA mice received 5 × 106 eosinophils from 
infected WT or IL-10-/- mice, or PBS every 48 h from 5 – 9 dpi. (E) Larval burdens in 
diaphragms, 17 dpi. (F) Numbers of CD4+IL-10+ cells and (G) CD4+IL-4+ cells in 
diaphragms of mice, 17 dpi. Each data set was collected from two experiments with 
similar results. Values represent mean ± SD; n = 3 - 4 mice. Significant differences 
were determined by Student’s t test or ANOVA and Tukey’s test. *p < 0.05, **p < 
0.001, ***p < 0.0001.  
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Discussion 
The aim of this study was to bring clarity to the striking and unexpected 
observation that eosinophils protect intracellular, muscle-stage T. spiralis larvae 
against NO-mediated killing. Testing two strains of eosinophil-ablated mice, 
engineered by two very different approaches, reduced the likelihood that the results 
are artifactual, and our experiments consistently replicate results in PHIL and 
ΔdblGATA mice. Adoptive transfer methods are powerful tools for examining the 
contribution of effector cell populations in such mice. We set out to address three 
questions: what are the crucial players in killing by NO, do eosinophils prevent killing 
via CD4+IL-10+  T cells, and when and how do eosinophils exert their influence? We 
discovered a dominant role for IL-10 throughout the immune response that culminates 
in the protection of larvae in muscle. 
 Our previous findings showed that growing larvae were at greatest risk for NO 
mediated killing and suggested that the combination of impaired growth and local NO 
that was evident in eosinophil-ablated mice was responsible for the high rate of larval 
clearance. Infection of Arg1-deficient mice showed that larval killing could occur in 
the absence of impaired growth. Similarly, growth is normal in IL-10-/- mice while 
local iNOS expression is high, and larval killing is evident (21, 29). Reduction in 
larval burdens at 28 days following oral infection is similar in these two strains (44% 
in Arg1flox/flox;Tie2cre, 50% in IL-10-/- ) and in ΔdblGATA (48%). PHIL mice 
consistently show a higher rate of clearance (67-77%), a finding that is unexplained. 
We speculate that IL-10 and Arg1 deficiencies yield much higher local NO that 
overcomes the contribution of impaired growth to net larval clearance that may occur 
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in eosinophil-ablated mice. The relationship between impaired growth and larval 
clearance requires further investigation. While CD4+CD25- T cells are critical sources 
of IL-10 that limits NO production by cells that infiltrate Trichinella-infected muscle 
(21, 24), the functions of eosinophils in supporting larval growth appear to operate 
independently of adaptive immunity (30), and are being investigated separately. In this 
report, we describe the processes associated with eosinophil-driven adaptive immunity 
that give rise to control of local NO production by T cells.  
 Taken together with earlier findings that inhibition of iNOS by drug treatment 
correlated with improved larval survival (20), that macrophages account for 80% of 
leukocytes at sites of infection, and that iNOS+ cells at sites of infection are largely 
macrophages and neutrophils (21), the results from Arg1flox/flox;Tie2cre mice support 
the conclusion that myeloid cells are important targets of eosinophil-dependent 
immune regulation during T. spiralis infection. Moreover, adoptive transfer of IL-10+ 
mDCs or CD4+ T cells to eosinophil-ablated mice compensated for eosinophils in 
protecting larvae from killing. This result indicates that eosinophils do not need to 
interact directly with macrophages or neutrophils in order to limit NO production, and 
further supports the conclusion that their influence is effected by promoting an 
adaptive immune response that is rich in IL-10.   
 In addition to limiting NO production, Arg1 is the key enzyme in collagen 
deposition by macrophages (31) . A collagen capsule is a defining feature of the 
Trichinella nurse cell and large numbers of macrophages are apposed to the capsule 
(32, 33).  Nevertheless, the nurse cell has been reported to supply collagen for the 
capsule (32). Although the expression of Arg1 is decreased in diaphragms of 
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eosinophil-ablated mice, capsule formation is normal in surviving nurse cells (20), 
indicating myeloid cells may be dispensable for collagen deposition. Normal larval 
growth in Arg1flox/flox;Tie2cre mice provides further, indirect evidence that local 
myeloid cells are not required for collagen capsule formation.  
 Eosinophils induce T cell responses by distinct mechanisms in different 
systems(13-16, 34). Restoring eosinophils to ablated, infected mice promoted the 
expansion of mDCs and CD4+IL-10+ T cells. We found no evidence that eosinophils 
promoted CD4+ T cell activation via antigen presentation, rather our data are 
consistent with an eosinophil influence on DC recruitment and activation that 
subsequently drives T cell differentiation. Importantly, CD11b+ mDCs, a DC subset, 
can initiate the production of IL-10 from T cells in helminth infections by secreting 
IL-10 (35-39). In allergic asthma, eosinophils have been shown to be required for 
accumulation of mDCs in the lung and draining lymph node (26). In T. spiralis 
infected, eosinophil-ablated mice, the reduction in CD11b+ mDCs at sites of infection 
and CLN was not likely the result of a deficient chemokine response (as is observed in 
asthma (26)) as gene expression of several chemokines known to be essential for 
recruitment of monocytes was normal in eosinophil-deficient infected tissue (data not 
shown). Although the deficiency in total cells is not readily explained by our data, 
clearly the cytokine profile of mDCs was influenced by eosinophils. IL-10 induces 
maturation of DCs, and triggers the secretion of IL-10 from DCs (39, 40). Thus, we 
speculate that in addition to promoting the accumulation of mDCs, eosinophils 
provide IL-10 that stimulates DCs to become IL-10 producers. This, in turn, creates a 
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suitable microenvironment for the development of CD4+IL-10+ T cells that limit iNOS 
expression and thereby protect larvae.  
 We speculate that mice mount innate and adaptive IL-10 responses in order to 
limit tissue injury and suppress immune-mediated inflammation caused by NBL, and 
that such a response coincidentally supports T. spiralis in establishment of 
intracellular infection.  Eosinophils were selectively recruited to skeletal muscle 
within hours of intravenous injection of NBL. This response is distinct from the well-
documented, T cell-dependent eosinophilia induced by T. spiralis that occurs several 
days after oral infection (41).  The innate response included increases in serum 
concentrations of three key mediators of eosinophil chemotaxis: IL-5, KC and 
RANTES (42). The nature of the assay performed did not reveal the source(s) of the 
chemokines and it is possible that they were derived from muscle, lung or other tissues 
that larvae enter during migration. The timing of detection in blood is consistent with 
the mediators being preformed rather than induced. We speculate that the release of 
these mediators is triggered by injury caused by large NBL (150 μm) that deploy a 
stylet to aid their exit from the blood and penetration of tissue. Endothelial cells 
express KC and RANTES, and rapidly secret them in response to injury (43, 44). 
Moreover, NBL activate the complement system (45), which may trigger tissue 
resident mast cells to release IL-5, KC and RANTES (46-49).  
The cellular sources and significance of IL-10 varies among helminth 
infections (50-55). By infecting IL-10 reporter mice, we observed that eosinophils in 
dLN and muscle produce IL-10 during T. spiralis infection. IL-10 was not detected in 
eosinophils in uninfected mice, indicating that it was induced by infection. The 
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immediate release of chemokines and recruitment of eosinophils to sites of infection 
are consistent with an innate response to injury caused by NBL. IL-10 is a feature of 
the response to injury, inhibiting inflammation and minimizing tissue damage (56). By 
regulating macrophage phenotype, IL-10 promotes muscle regeneration and growth 
(57).  
Injured tissues can release mediators known for initiating the IL-10 response, 
including IL-6 and IL-27 (58, 59). In T. spiralis infection, serum IL-6 was 
dramatically increased at 6 h after NBL injection. Exercise-associated muscle injury 
induces increase of muscle-derived IL-6 in plasma (58), and the transient increase of 
IL-6 may enhance production of IL-10 (60). Both IL-6 and IL-27 influence T cell 
populations to produce IL-10 (61-64). We detected increased expression of IL-27 as 
well as increased numbers of IL-27 receptor expressing eosinophils at sites of 
infection (Huang and Appleton, unpublished data), suggesting a potential role for IL-
27 in triggering eosinophils to secret IL-10; however, pilot experiments showed only a 
modest trend towards decreased larval burdens in IL-27 receptor deficient mice, with a 
partial improvement in larval survival following adoptive transfer of normal 
eosinophils to receptor deficient mice. Thus, although IL-27 may contribute, it does 
not fully account for IL-10 induction in eosinophils at sites of infection. The influence 
of IL-6 on eosinophils merits further investigation.      
IL-25 and IL-33 are found in endothelial cells and function as alarmins during 
inflammation. Both are known to stimulate ILC2 (65) to release IL-5 and IL-13, which 
in turn activate T helper cells and recruit eosinophils (66). The timing of eosinophil 
recruitment was not consistent with a role for ILC2 in nucleating this innate eosinophil 
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response, and indeed, infection of Rag2-/-γc-/- mice showed normal muscle 
eosinophilia and larval survival. Although it has been shown that ILC2 is essential for 
maintaining the integrity of mucosal sites, such as clearance of intestinal helminths 
and promoting tissue repair after helminth infections (67-69), our data support a 
dispensable role for ILC2 in muscle infection. 
Study of T. spiralis infection in mice is particularly valuable because there are 
very few natural animal models of either tissue-dwelling helminth infection or skeletal 
muscle responses to injury caused by infection. By combining eosinophil ablation and 
restoration with this natural infection, our findings document a novel 
immunoregulatory function of eosinophils. By entering sites of infection immediately 
following tissue invasion by T. spiralis larvae, eosinophils deploy IL-10 that expands 
IL-10-secreting DCs and CD4+ T cells, thereby controlling the activation of 
proinflammatory macrophages and neutrophils that otherwise kill parasite larvae by 
releasing NO. We speculate that Trichinella has adapted to its host by exploiting a 
mechanism that is in place to limit tissue injury. The remarkable functional versatility 
of eosinophils that has become increasingly evident recently is an important 
consideration in devising strategies for new prophylactic and therapeutic approaches 
to reducing the burden of parasitic worm infections.  
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CHAPTER 3 
 
Eosinophils mediate protective immunity against secondary nematode infection* 
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Abstract 
Eosinophils are versatile cells that regulate innate and adaptive immunity, 
influence metabolism and tissue repair, and contribute to allergic lung disease. Within 
the context of immunity to parasitic worm infections, eosinophils are prominent yet 
highly varied in function. We have shown previously that when mice undergo primary 
infection with the parasitic nematode, Trichinella spiralis, eosinophils play an 
important, immune regulatory role that promotes larval growth and survival in skeletal 
muscle. In this study, we aimed to address the function of eosinophils in secondary 
infection with T. spiralis. By infecting eosinophil-ablated mice, we found that 
eosinophils are dispensable for immunity that clears adult worms or controls fecundity 
in secondary infection. In contrast, eosinophil ablation had a pronounced effect on 
secondary infection of skeletal muscle by migratory newborn larvae. Restoring 
eosinophils to previously infected, ablated mice caused them to limit muscle larvae 
burdens. Passive immunization of naïve, ablated mice with sera from infected donors, 
together with transfer of eosinophils, was effective in limiting the number of newborn 
larvae that migrated in tissue and colonized skeletal muscle. Our results are 
compatible with earlier reports from in vitro experiments that have informed the 
dogma that eosinophils bind to larvae in the presences of antibodies. These findings 
document a third function for eosinophils in T. spiralis infection.  
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Introduction 
Parasitic worms are estimated to infect two billion people worldwide and 
nearly 1 billion children live in areas of high transmission (1). Although drug therapy 
is often effective in clearing infections, reinfection rates are high (2), consistent with 
poorly sustained immunity. A relatively small number of anthelmintic drugs are 
available and the efficacy of anthelmintics is known to be limited by the emergence of 
drug resistant parasites (3-5). Advancing vaccination as a more sustainable alternative 
to chemotherapy requires understanding of immune mechanisms that are effective in 
preventing or clearing infection.  
Clearance of worm infections occurs by mechanisms that vary among 
parasites, the hosts they infect, and the tissues they colonize (6). As is the case with 
other pathogens, mechanisms of immunity in primary worm infection often differ 
from those that are effective in preventing or clearing secondary infection. There is 
extensive evidence supporting key roles for Th2 cells in clearing primary, intestinal 
infections, although the effector mechanisms vary (7-9). Additional evidence 
documents important contributions of B cells and antibodies in controlling secondary 
infections and also in vaccine induced protection (10-13). In the case of the parasitic 
nematode, Trichinella spiralis, T cell-mediated immunity that drives intestinal 
mastocytosis in primary infection is central to the mechanism of worm clearance in 
rats and mice (14-16); however, mast cell activation is neither necessary nor sufficient 
for antibody-mediated protection that clears larval stages from rats during a secondary 
intestinal infection (17-19). Mice do not demonstrate this same, antibody-mediated 
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immunity to secondary infection but instead manifest worm expulsion that is 
accelerated but similar to that observed in primary infection (20). 
Intestinal mastocytosis during primary T. spiralis infection occurs 
simultaneously with a pronounced tissue eosinophilia (21). In vitro studies have 
shown that eosinophils are capable of adhering to and killing several species of 
parasitic worms. In some species, including T. spiralis, killing occurs only in the 
presence of specific antibodies (22, 23). These findings served to set a paradigm for 
eosinophils as cytotoxic effector cells in worm infection. Early investigations of 
eosinophil effector function in vivo were performed by antibody-mediated depletion of 
eosinophils or manipulating IL-5 in mice. Findings from studies conducted with 
various worm infections supported a role for IL-5 in some cases (24, 25) and not in 
others (26). Subsequently, experiments with eosinophil-ablated mice have shown that 
eosinophils are dispensable in immunity to primary infections with intestinal worms 
(27-31). Secondary infections are less well studied, but challenge of eosinophil-
ablated mice revealed that eosinophils contribute to protective immunity against 
Nippostrongylus brasiliensis by interfering with larval migration (30).  
In contrast, results from infections with worms that colonize extraintestinal 
sites, including T. spiralis, show that eosinophils are beneficial to the parasite during 
primary infection (29, 32, 33). Trichinella completes its life cycle in a single host. 
Infective first-stage larvae are ingested and mature into adult worms in the intestine, 
where they reproduce and release newborn larvae (NBL). NBL enter the circulatory 
system and transit the lung (34) prior to arriving in skeletal muscles. Larvae invade 
myotubes and establish chronic, intracellular infection. By infecting eosinophil-
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ablated mice, we have shown that in primary infections, eosinophils are required for 
efficient growth as well as survival of muscle larvae (29, 32). Survival is promoted via 
control of local NO-production by an eosinophil-driven IL-10 response (29, 32, 35, 
36). The effect of eosinophil ablation on secondary infection has not been tested. 
Previous studies in IL-5-deficient or -depleted mice yielded contradictory results (26, 
37). The unexpected properties of eosinophils in primary T. spiralis infection and the 
contradictory results between in vitro and in vivo studies of eosinophil function 
prompted us to test the contribution of eosinophils to secondary immunity to T. 
spiralis using eosinophil lineage-ablated mice. 
We report here that eosinophils are required for effective immunity to 
secondary infection by T. spiralis.  Although eosinophil ablation had no effect on 
intestinal immunity, it was associated with enhanced colonization of skeletal muscle.  
Transfer experiments showed that eosinophils interfered with migration of NBL, an 
effect that was dependent on the presence of immune serum. The results provide 
evidence in support of an antibody-dependent mechanism in which eosinophils limit 
secondary infection by T. spiralis.  
 
 
 
 
 
 
 
 72 
Materials and Methods 
Rats and mice 
Adult Albino Oxford strain rats were produced and maintained in the Baker 
Institute vivarium. PHIL, ΔdblGATA, MBP-/-, EPX-/- and IL-5-expressing transgenic 
(NJ.1638) (IL-5Tg+) mice were bred at Cornell Transgenic Mouse Core Facility and 
offspring were transferred to the Baker Institute. All strains were on a C57BL/6 
background. C57BL/6 NHsd mice were purchased from Taconic as wild type (WT) 
controls. Animal care was in accordance with the guidelines of the Association for 
Assessment and Accreditation of Laboratory Animal Care and experiments were 
performed with the approval of the Institutional Animal Care and Use Committee of 
Cornell University. 
 
Parasite and Antigens 
Trichinella spiralis first-stage larvae (L1) and newborn larvae (NBL) were recovered 
from rats as described previously (29). For oral infection, L1 were suspended in 2% 
nutrient broth (Difco), 0.6% gelatin (Fisher Scientific) and doses of 300 L1 were 
administered by gavage. For synchronous infection, 25,000 NBL were suspended in 
0.25 ml serum-free DMEM (Mediatech, Inc.) and delivered by retro-orbital injection. 
Mice were euthanized by CO2 inhalation at the times indicated in each experiment. 
Whole body muscle larvae burdens were assessed in whole carcasses 28 days post-
infection (dpi) as described previously (29). Intestinal worm burdens were estimated 
as described previously. To determine the numbers of NBL in the lung, the whole lung 
was surgically isolated and disrupted on a tea strainer. Tissue suspensions were 
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centrifuged and resuspended in 10% formalin. NBL were counted using a phase 
contrast microscope. Crude somatic antigens from L1 were prepared as previously 
described (29).  
 
Challenge infection, sera collection and passive immunization 
Mice were infected with 300 L1 and challenged with the same dose after 90 
days. Immune sera were collected from WT or ΔdblGATA mice 28 days following re-
infection. Normal sera were collected from naïve WT mice. For passive immunization, 
mice were injected intraperitoneally with 0.2 ml serum from naïve or infected mice. 
 
Enzyme-linked immunosorbent assay (ELISA) 
Cells from cervical lymph nodes (CLN) or mesenteric lymph nodes (MLN) 
were cultured, stimulated with antigen, and supernatants were assayed for IL-4, IL-5, 
IL-10, IL-13 and IFN-γ, as described previously (32). Serum antibodies specific for T. 
spiralis antigens were measured as described previously (17). Mouse sera were diluted 
1:2000 for IgG1, or 1:100 for IgG2c. IgG1 was detected with rat anti-mouse IgG1 (BD 
PharMingen) and biotinylated mouse anti-rat IgG (BD PharMingen) followed by 
HRP-conjugated streptavidin (BD Biosciences). IgG2c was detected with goat anti-
mouse IgG2c (Immunology Consultants Laboratory) and HRP-conjugated rabbit anti-
goat IgG (Immunology Consultants Laboratory). 
 
Eosinophil transfer experiments 
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Eosinophils were recovered from infected IL-5Tg+ mice 12-20 dpi. Cells were 
pooled from spleens and peritoneal lavage fluid and purified by positive selection on 
magnetic beads, as previously described (32). Briefly, eosinophils were labeled with 
PE-conjugated anti-Siglec-F antibody (BD) and anti-PE microbeads (Miltenyi Biotec). 
Average purity of eosinophils from this procedure was >93%. After washing twice 
with PBS, 5 × 106 eosinophils were resuspended in 200 µl sterile PBS and injected i.v. 
into ΔdblGATA mice. Cells were transferred 4 times, on alternate days, for 8 days. 
 
Flow cytometry 
Cells from individual diaphragms were recovered as described previously (32). 
After a 15 min incubation with Fc block (eBioscience) and 10% normal mouse serum, 
cells were incubated for 15 min with PE conjugated anti-SiglecF (BD Pharmingen). 
Data were acquired using a Gallios flow cytometer (Beckman Coulter) and analyzed 
with FlowJo software (Tree Star) 
 
Worm fecundity 
Worm fecundity was determined as described (38). Briefly, female worms 
were recovered from the small intestines of C57BL/6 and ΔdblGATA mice, 6 days 
following primary or secondary infection with 300 L1. Individual female worms were 
placed in 100 µl of RPMI1640 containing 10% FCS in a single well of a 96-well plate 
and incubated at 37 °C for 24 h in 5% CO2. The number of shed NBL was counted 
under a microscope. At least ten female worms were collected from each mouse, and 
the mean NBL value per mouse was used to calculate means for each treatment group.  
 75 
 
ATP content measurement  
100 adult worms were collected from individual mice as described (39). 
Worms were washed three times and boiled for 15 min in 100 µl PBS. Lysates were 
centrifuged 10,000 × g for 10 min at 4 °C. ATP was measured in supernatants with an 
ENLITEN ATP Assay System Bioluminescence Detection Kit (FF2000, Promega, 
Madison, WI).    
    
Statistical analysis 
All experiments were performed twice with similar results. Means ± SD were 
calculated from data collected from individual mice unless otherwise indicated. 
Significant differences were determined using Student’s t test or one-way ANOVA 
with Tukey’s post hoc test for multiple means. Statistical analysis was performed with 
GraphPad Prism 5 software.  
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Results  
Eosinophils are dispensable for intestinal immunity against secondary T. spiralis 
infection. 
To investigate the role of eosinophils in secondary infection of T. spiralis, we 
first examined parameters of intestinal infection in eosinophil-ablated mice. We 
infected WT and ΔdblGATA mice with 300 larvae and then challenged them with the 
same dose 90 days later (1°+2°). A group of naïve mice received larvae at the 90 day 
time point in order to document the primary immune response (challenge control) 
(Fig. 3.1. A). Cytokine production by antigen-stimulated MLN cultures was similar in 
WT and ΔdblGATA mice (Fig. 3.1. B). The rate of intestinal worm expulsion was 
similar in the two strains in primary infection, and was similarly accelerated in 
secondary infection (Fig. 3.1. C). Worm fecundity and ATP content of male and 
female worms were not significantly different between strains in either infection (Fig. 
3.1. D and E). Taken together, the results indicate that eosinophil ablation did not 
influence the outcome of intestinal infection by T. spiralis. Therefore, any differences 
in either NBL migration or muscle larvae burden in eosinophil-ablated vs. WT mice 
that may be observed following intestinal infection would be attributed to 
extraintestinal effects of eosinophils and not to differences in ‘doses’ of NBL 
produced by intestinal worms.  
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Figure 3.1. Eosinophils are dispensable for intestinal immunity against T.spiralis 
infection. (A) Design of experiments indicating timing of sample collections. D, day. 
(B) Cytokine responses in MLN of WT and ΔdblGATA mice. (C) Adult worms in 
intestines of WT and ΔdblGATA mice during primary or secondary infection. (D) 
Fecundity of female adult worms and (E) ATP content of adult males and females 
recovered from the intestines of WT and ΔdblGATA mice during primary or 
secondary infection. Each data set was collected from two experiments with similar 
results. Values represent mean ± SD; n = 3 - 4 mice. Significant differences were 
determined by ANOVA and Tukey’s test. ***p < 0.0001. 
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Eosinophils prevent the accumulation of muscle larvae in secondary infection 
The influence of eosinophils on extraintestinal parasites, specifically migrating 
NBL and larvae that colonize skeletal muscle, was tested in experiments similar in 
design to those described above, but with an additional control group that received 
only the first infection (infection control) (Fig. 3.2. A). Cytokines were assayed in 
CLN cultures, as these nodes drain the tongue and masseter, preferred sites of 
colonization by NBL. Antigen-stimulated CLN cultures prepared from ΔdblGATA 
mice 17 days after secondary infection produced less IL-4 and than WT cells. This 
finding is similar to that observed in primary infection and reported previously (29, 
32). IL-10 was reduced in both primary and secondary infection.  No differences were 
observed in IL-5, IL-13 and IFN-γ (Fig. 3.2. B) in secondary infection, although IFN-γ 
was increased in cultures from ablated mice undergoing primary infection, as reported 
previously (29, 32).   
WT mice prevented the accumulation of additional muscle stage larvae while 
ΔdblGATA mice did not show this resistance, i.e. their muscle burdens equaled the 
combined burdens of the two infection control groups (Fig. 3.2. C). While few if any 
migrating NBL were recovered from lungs of WT mice ten days post-secondary 
infection, the number recovered from lungs of ΔdblGATA mice was significantly 
higher and was not different from that of the challenge control mice (Fig. 3.2. D). 
Thus, eosinophils appeared to limit larval establishment in muscle by interfering with 
migration of NBL.  
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Figure 3.2. Eosinophils influence secondary immunity to muscle infection and 
limit the migration of NBL. (A) Design of experiments indicating timing of sample 
collections. D, day. (B) Cytokine responses in CLN cultures of WT and ΔdblGATA 
mice. (C) Whole body muscle larval burdens in WT and ΔdblGATA mice. (D) 
Numbers of NBL in lungs recovered from WT and ΔdblGATA mice. Each data set 
was collected from two experiments with similar results. Values represent mean ± SD; 
n = 3 - 5 mice. Significant differences were determined by Student’s t test or ANOVA 
and Tukey’s test. *p < 0.05, **p < 0.001, ***p < 0.0001. 
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Specific antibodies are required for eosinophil-mediated protection against 
secondary muscle infection 
To confirm that eosinophils are required for the resistance to re-infection, we 
performed eosinophil transfer experiments. Restoring eosinophils to previously 
infected ΔdblGATA mice between days 4 and 10 following oral challenge infection 
resulted in fewer larvae maturing in skeletal muscle (Fig. 3.3. A). [This result is the 
opposite of that observed when a nearly identical transfer protocol is applied to 
primary infection. In that case, larval burdens are increased in ΔdblGATA eosinophil 
recipients (32) (Fig. 3.3. D, see naïve sera plus eosinophils).] With this result, we 
hypothesized the eosinophils clear migrating larvae from tissues by working in concert 
with immune effectors that were induced by prior infection. Although it has not been 
documented in vivo, binding of antibodies to the body surfaces of newborn larvae has 
been shown to promote eosinophil adhesion and degranulation in vitro (23). In order 
to test the protective effects of serum antibodies, we passively immunized naïve 
ΔdblGATA mice with sera from naïve or immune WT mice. The next day, eosinophils 
were restored to recipients and mice were infected intravenously with NBL (Fig. 3.3. 
B). [Note that we used intravenous infection rather than oral infection in order to avoid 
any unknown effects of immune sera on intestinal infection that might have altered the 
release of NBL by adult worms.] Compared to ΔdblGATA mice that received naïve 
serum and eosinophils, there were fewer NBL in lungs of ΔdblGATA mice that 
received both immune serum and eosinophils (Fig. 3.3. C). Consistent with previous 
findings, eosinophils improved muscle survival in ΔdblGATA mice that received  
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Figure 3.3. Eosinophils cooperate with immune sera. (A) Whole body muscle larval 
burdens in WT and ΔdblGATA mice, 28 days post-challenge. ΔdblGATA mice 
received 5×106 eosinophils or PBS every 48 h between 4 and 10 days post-challenge. 
(B) Design of experiments indicating timing of sample collections. D, day. (C) 
Numbers of NBL in lungs recovered from ΔdblGATA mice, 12 h post infection. (D) 
Whole body muscle larval burdens in ΔdblGATA mice, 24 dpi. Each data set was 
collected from two experiments with similar results. Values represent mean ± SD; n = 
4 mice. Significant differences were determined by ANOVA and Tukey’s test. *p < 
0.05, **p < 0.001. 
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naïve serum; however, transfer of eosinophils to ΔdblGATA mice that received 
immune serum did not improve burdens (Fig. 3.3. D). Taken together, the results 
support a mechanism in which specific antibodies enable eosinophils to defend against 
muscle infection by limiting the migration of NBL. In addition, eosinophils and 
immune sera were sufficient to limit larval colonization of skeletal muscle in 
otherwise naïve mice, indicating that other immune effectors are not required. 
 
Effect of eosinophils on plasma cells and generation of specific antibodies 
Eosinophils have been demonstrated to be required for long-term maintenance 
of plasma cells in the bone marrow (40, 41). We tested whether eosinophils influence 
the number of plasma cells or the quantity and qualities of antibodies produced during 
T. spiralis infection. Consistent with published findings, there were fewer CD138+ 
plasma cells in the bone marrow in naïve, eosinophil-ablated mice (Fig. 3.4. A); 
however, the difference was not evident after 90 days of infection (Fig. 3.4. A). The 
number of plasma cells in spleen was not influenced by eosinophil ablation (Fig. 3.4. 
B). We next compared the IgG1 and IgG2c responses mounted against parasite 
antigens by WT and ΔdblGATA mice. Serum IgG1 was similar between the two 
strains (Fig. 3.4. C); however, serum IgG2c was significantly reduced in eosinophil-
ablated mice that were infected and challenged (Fig. 3.4. D). To test the significance 
of the difference in isotype composition, we passively immunized naïve ΔdblGATA 
mice with sera from naïve WT, immune WT, or immune ΔdblGATA mice, then 
restored eosinophils and infected mice with NBL (Fig. 3.3. B). Immune sera from WT 
or ΔdblGATA mice were equally effective in limiting NBL migration to the lung (Fig.  
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Figure 3.4. Isotype response is influenced by eosinophils. Percentage of CD138+ 
plasma cells in (A) bone marrow and (B) spleen of naive or 90 dpi WT and PHIL 
mice. Level of T.spiralis crude antigen specific (C) IgG1 and (D) IgG2c in serum 
collected from WT and ΔdblGATA mice. 1° + 2°, mice were infected on day 0 (1°), 
reinfected on day 90 (2°), and serum collected 28 days after 2° infection. Infection 
ctrl, serum collected 118 dpi. Challenge ctrl, serum collected 28 dpi. (E) Numbers of 
NBL in lungs recovered from ΔdblGATA mice, 12 h post infection. ΔdblGATA mice 
were passively immunized with sera from naïve or immune WT or ΔdblGATA mice, 
intravenously infected with 25000 NBL following eosinophils transfer. Each data set 
was collected from two experiments with similar results. Values represent mean ± SD; 
n = 3-4 mice. Significant differences were determined by Student t test or ANOVA 
and Tukey’s test. *p < 0.05, ***p < 0.0001.  
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3.4. E). Thus, the difference in antibody isotype did not influence the protection 
afforded by immune sera and immunes sera and eosinophils were sufficient to confer 
protection. 
 
Eosinophils are recruited to sites of infection in secondary infection 
Our previous studies have demonstrated that eosinophils promote muscle 
larvae survival in primary infection by limiting local production of toxic NO (29, 32). 
When eosinophils are absent, NO is produced and growing larvae are killed.  We 
tested the hypothesis that during secondary infection, eosinophils are prevented from 
reaching skeletal muscle, speculating that they may become encumbered in tissues by 
immune complexes formed by antibodies and NBL antigens, and that this would 
prevent eosinophil traffic to muscle. By recovering cells from skeletal muscle 
following our protocol of passive immunization with eosinophil transfer, we found 
that recruitment of eosinophils to muscle after NBL injection was normal in 
ΔdblGATA mice (Fig. 3.5. A). In a different experiment, eosinophils infiltrated 
muscle normally in WT mice following oral challenge (Fig. 3.5. B). Both experiments 
documented that eosinophils access skeletal muscle efficiently in secondary infection 
and support the conclusion that the effector mechanism that limits colonization of 
muscle involves antibody-dependent, eosinophil-mediated interference with NBL 
migration.       
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Figure 3.5. Eosinophils are recruited to sites of infection in secondary infection. 
(A) Numbers of eosinophils in diaphragms recovered from ΔdblGATA mice, 12 h 
post infection with NBL. Experimental design is diagramed in Fig. 3.3. B. (B) 
Numbers of eosinophils in diaphragms recovered from WT mice. Experimental design 
is diagramed in Fig. 3.2. A. Each data set was collected from two experiments with 
similar results. Values represent mean ± SD; n = 4 mice. Significant differences were 
determined by Student t test or ANOVA and Tukey’s test. **p < 0.001, ***p < 
0.0001. 
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Discussion 
Parasitic worms deploy a variety of strategies to evade or co-opt the immune 
response.  Trichinella spiralis is a natural parasite of rodents, providing an accessible 
and readily manipulated life-cycle for the study of these mechanisms. When combined 
with passive transfer and adoptive transfer methods, eosinophil-ablated mice have 
proven to be powerful tools for investigating the role of eosinophils at the host/parasite 
interface. We observed that when re-infected with T. spiralis, ablated mice failed to 
manifest immunologic memory that normally limits colonization of skeletal muscle by 
larvae.  This observation supported a key role for eosinophils in protection against 
super-infection. 
Three life stages of T. spiralis encounter eosinophils during the course of 
infection: adult worms in the intestine, migrating NBL that enter a variety of tissues, 
and muscle larvae that mature intracellularly in skeletal muscle. Despite the 
abundance and the prominence of eosinophils in the intestinal immune response, they 
are not required for adult worm clearance in primary infection (29). Similarly, 
eosinophils fail to influence both worm expulsion and Th2 immunity in primary 
infection by the closely related nematode, Trichuris muris (28). In secondary infection 
by T. spiralis, intestinal worm expulsion was accelerated; however, the absence of 
eosinophils did not influence the clearance of worms, the fecundity of female adult 
worms, or ATP content of male and female adults. Although the mechanism of 
secondary intestinal immunity against T. spiralis adult worms has not been thoroughly 
investigated, memory T cells are important for expulsion of intestinal worms (42, 43) 
and IL-4R signaling is crucial to worm expulsion in primary infection (7). Cytokine 
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production in MLN of ablated and WT mice supported the conclusion that antigen-
induced IL-4 production was not altered by eosinophil ablation.  Our results indicate 
that eosinophils are not required for the expression of intestinal immunity during 
secondary infection by T. spiralis. 
The finding that eosinophil-ablated mice failed to prevent the accumulation of 
muscle larvae during secondary infection suggested that immunologic memory may be 
compromised. Th2 memory cells express IL-25 receptor and eosinophils are capable 
of influencing Th2 memory cell function by secreting IL-25 (44). During secondary 
infection by T. spiralis, IL-4 and IL-10 were significantly reduced in CLN of 
ΔdblGATA mice, consistent with memory Th2 responses being impacted in muscle. 
Despite this deficiency, transfer of eosinophils to previously infected ΔdblGATA mice 
conferred protection against the secondary infection. Furthermore, transfer of 
eosinophils and immune serum to naïve mice was protective. Moreover, serum from 
ΔdblGATA mice was as effective as serum from WT mice in conferring immunity. 
Therefore, although T cell responses and development of memory T cells was 
influenced by eosinophils, activation of memory T cells was not required for 
eosinophils to limit migration of NBL. Similary, although antibody production was 
influenced by eosinophils, the influence did not compromise the protection afforded 
by immune serum. 
In accordance with early in vitro studies (23, 45-47), the influence of 
eosinophils on NBL in vivo was dependent on the presence of immune serum, most 
probably specific antibodies. Mouse eosinophils express Fcα and Fcγ receptors (48, 
49), but do not express Fcε receptors (50). Complement has been shown to be 
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important for immunity to parasitic infections (51-53), and T. spiralis NBL are potent 
activators of complement (54). Furthermore, mouse eosinophils express functional 
complement receptors (55). The effect of immune serum may be mediated via 
complement receptors, Fc receptors, or some combination and requires further 
investigation. 
Eosinophil granule proteins have been implicated as key to effector function. 
The two most abundant granule proteins in mouse eosinophils, major basic protein 
(MBP) and eosinophil peroxidase (EPX) (56), are required for protective immunity 
against Strongyloides stercoralis and Litomosoides sigmodontis in mice (31, 57). Both 
MBP and EPX are capable of killing T. spiralis NBL in vitro (47, 58); however, 
deletion of the genes encoding either MBP or EPX does not affect the capacity of mice 
to control primary T. spiralis infection (32). In secondary infection, results of pilot 
studies indicate that infected MBP-/- and EPX-/- mice were similar to WT mice in 
resisting secondary infection (Huang and Appleton, not shown). It is possible that 
MBP and EPX are functionally redundant, so that deleting both genes would be 
required to document their action against NBL in vivo; however, testing this 
hypothesis directly is not possible, because MBP and EPX double knockout mice lack 
eosinophils (59). Other granule proteins, such as eosinophil cationic protein (ECP), 
appear to be potent toxins and may be important (46). Alternatively, eosinophils may 
act through a granule protein-independent mechanism, for example, by adhering to 
and entrapping NBL as they move through tissue. This may be a two-step process, in 
which antibodies impede the movement of highly motile NBL such that the much less 
motile eosinophil can approach and adhere. Recent reports suggest that antibodies are 
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capable of cooperating with basophils or alternatively activated macrophages to 
impede the mobilization of larvae (60, 61). 
Our results show that the longstanding paradigm of defensive function for 
eosinophils against helminth infection is valid and highly significant in T. spiralis 
infection. Previously, we have reported that eosinophils support rather than limit 
colonization of skeletal muscle during primary infection by T. spiralis (29, 32). In this 
context, the mechanism by which eosinophils support larval growth in muscle is 
distinct from the mechanism of immune regulation that limits local NO synthesis (36, 
62). We have speculated that these two, distinct eosinophil-mediated effects cooperate 
to promote survival of larvae in muscle. The host-protective function of eosinophils in 
the response to challenge represents a third role for eosinophils in T. spiralis infection. 
Understanding all of the contributions of eosinophils to immunity mounted in 
response to parasitic worms will be crucial to the development of effective vaccines 
and therapeutic interventions. 
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Eosinophil-derived IL-4 promotes nematode growth in an innate context* 
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Abstract 
It has become increasingly clear in recent years that the function for 
eosinophils in health and disease is highly varied. Recent studies have revealed novel 
aspects of eosinophil function in metabolism and tissue regeneration. Such 
mechanisms provide new clues in the investigation of the roles of eosinophils in 
parasitic worm infections. The aim of this study was to investigate the mechanism 
underlying the observation that eosinophils promote growth of Trichinella spiralis 
larvae in skeletal muscle. Our results indicate that normal larval growth requires IL-4 
and STAT6 signaling that are intrinsic to eosinophils. The effect occurs independently 
of adaptive immunity. Gene expression array data were compatible with a muscle 
regenerative response to newborn larvae and a shift in the source of energy in infected 
cells. The results suggest that eosinophil-derived IL-4 promotes larval growth by 
enhancing glucose uptake in nurse cells. Our findings document a novel interaction 
between worms and host, in which worms have evolved a strategy to co-opt a host cell 
function to facilitate their own growth. 
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Introduction 
Genomic analysis of diverse members of the Nematoda has revealed that free-
living nematodes evolved to become parasitic not once, but several times (1). The 
process of host adaptation is associated with loss of functions that enable a free-living 
lifestyle. Understanding these dependencies is invaluable to devising therapeutic and 
prophylactic approaches to controlling parasitic disease. Animal hosts often mount 
potent Th2 immune responses that can be highly effective in limiting worm infections, 
although effecter mechanisms vary by host, tissue and parasite. As counterpoint, 
helminths deploy mechanisms to evade or co-opt the host immune response in ways 
that ensure completion of life cycle and transmission to the next host. In one example, 
schistosomes are capable of manipulating innate immune signals and Th2 immunity to 
facilitate their development (2, 3).  
Eosinophilia is a hallmark of the response to parasitic worms. Long considered 
to be cytotoxic effector cells that kill parasitic larvae, recent studies in eosinophil-
ablated mice have shown that the contributions of eosinophils are dispensable or 
beneficial to certain parasitic worms (4-7). For instance, the filarial worm 
Litomosoides sigmodontis develops faster and alters reproduction in response to IL-5 
induced eosinophilia (8). Moreover, recent studies have revealed novel contexts in 
which eosinophils regulate metabolism and tissue regeneration (9-12). Such 
mechanisms have potential to be highly significant in the intimate, dependent 
relationship between parasite and host. 
After being released from female adult worms in the intestine, Trichinella 
spiralis newborn larvae (NBL) enter the circulatory system, migrate in a variety of 
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tissues and eventually establish intracellular infection in skeletal muscle. Following 
invasion of skeletal muscle cells, NBL remain inactive for 4 days prior to initiating 
growth from 130 µm to 1 mm in length over the course of 20 days (13). Our previous 
studies demonstrated that eosinophils are recruited to muscle upon NBL arrival and 
positively regulate both survival and growth of larvae (4, 6, 14). Support of larval 
survival is dependent on IL-10 production that is intrinsic to eosinophils, which in turn 
drives production of CD4+IL-10+ cells that suppress local nitric oxide (NO) 
production. NO is toxic for NBL and growing larvae (4, 14).  
Support of growth occurs independently of IL-10 by a distinct mechanism (4). 
In the current study, we aimed to reveal the mechanism underlying eosinophil-
dependent growth of muscle larvae. Our results reveal a requirement for IL-4/STAT6 
signaling in eosinophils, and eosinophils supported larval growth independently of 
adaptive immunity. Microarray analysis indicated that infection by NBL induces 
dynamic changes on genes transcription, consistent with a muscle regenerative 
response and a shift in the source of energy in infected tissue. Redistribution of 
glucose transporter 4 (GLUT4) and phosphorylation of Akt were observed in nurse 
cells, compatible with enhancement of glucose uptake. The results implicate 
eosinophil-derived IL-4 in promoting larval growth by enhancing glucose uptake in 
nurse cells. These findings provide evidence for a parasitic adaptation in which the 
recruitment of eosinophils provides a nutrient-rich environment that facilitates larval 
growth. 
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Materials and Methods 
Rats and mice 
Adult Albino Oxford strain rats were produced and maintained in the Baker 
Institute vivarium. PHIL, ΔdblGATA, Rag1-/-, PHIL/Rag1-/- and IL-5-expressing 
transgenic (NJ.1638) (IL-5Tg+), IL-5Tg+/IL-4-/- and IL-5Tg+/STAT6-/- mice were bred 
at Cornell Transgenic Mouse Core Facility (TMCF) and offspring were transferred to 
the Baker Institute. IL-4-/- and STAT6-/- were purchase from The Jackson Laboratory 
and the bred at TMCF. PHIL/Rag1-/-, IL-5Tg+/IL-4-/- and IL-5Tg+/STAT6-/- mice were 
generated by crossing and backcrossing on the deficient strains and genotype was 
confirmed by PCR. Rag2-/-γc-/- and B6.SJL mice were purchased from Taconic. IL-13-
/- mice were a gift from Dr. Avery August (Cornell) and Dr. Thomas Wynn (NIAID). 
PHIL mice were genotyped as described previously (15). All strains were on a 
C57BL/6 background. C57BL/6 NHsd mice were purchased from Taconic as wild type 
(WT) control. Animal care was in accordance with the guidelines of the Association 
for Assessment and Accreditation of Laboratory Animal Care and experiments were 
performed with the approval of the Institutional Animal Care and Use Committee of 
Cornell University. 
 
Parasite and Antigens 
Trichinella spiralis first-stage larvae (L1) and newborn larvae (NBL) were 
recovered from rats as described previously (6). For oral infection, L1 were suspended 
in 2% nutrient broth (Difco), 0.6% gelatin (Fisher Scientific) and doses of 300 L1 were 
administered by gavage. For synchronous infection, 25,000 NBL were suspended in 
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0.25 ml serum-free DMEM (Mediatech, Inc.) and delivered by retro-orbital injection. 
Mice were euthanized by CO2 inhalation at the times indicated in each experiment. 
Whole body muscle larvae burdens were assessed in carcasses 28 days post- oral 
infection (dpi) or 24 days post-NBL injection as described previously (6). Crude 
somatic antigens from L1 were prepared as previously described (6).  
 
Parasite measurement 
Body area was measured as described previously (4). Briefly, developing L1 
larvae were recovered (17 dpi) by digesting minced diaphragms for 15 min at 37°C in 
PBS containing 2% FCS and 5 mg/ml collagenase I (Sigma). Larvae were treated with 
70% ethanol (warm up at 56°C) overnight. Larvae were then centrifuged and 
resuspended in 5% glycerol/70% ethanol for one day and then transferred to slides 
using a Cytospin. Slides were fixed with methanol and stained with HEMA-3 (Fisher 
Healthcare), and measurements were performed using a BX51 microscope. The area 
of each larva was calculated using Microsuite Basic Olympus software. At least 25 
larvae were measured per mouse, and values are expressed in µm2.  
 
Bone marrow chimeras and flow cytometry 
6- to 8-week old B6.SJL (CD45.1) or STAT6-/- (CD45.2) were provided with 
acidified water (pH 2-3) containing 1 mg/ml gentamicin sulfate solution 1 week prior 
to lethal gamma irradiation (950 cGy), followed by retro-orbital injection with 107 
bone marrow cells isolated from femurs of STAT6-/- or B6.SJL mice, respectively. 
Reconstitution was confirmed by detection of leukocytes bearing congenic markers by 
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flow cytometry eight weeks after transplantation. Spleen cells from recipients were 
incubated with Fc block in 2% FBS containing PBS, followed by staining with FITC-
conjugated anti-mouse CD45.1 (Biolegend) and Alexa Fluor 700-conjugated anti-
mouse CD45.2 (eBioscience). Data were acquired using a Gallios flow cytometer 
(Beckman Coulter) and analyzed with FlowJo software (Tree Star).      
 
Eosinophil transfer experiments 
Eosinophils were recovered from infected IL-5Tg+, IL-5Tg+/IL-4-/- or IL-
5Tg+/STAT6-/- mice 12-20 dpi. Cells were pooled from spleens and peritoneal lavage 
fluid and purified on magnetic beads as previously described (16). Briefly, eosinophils 
were labeled with PE-conjugated anti-Siglec-F antibody (BD) and anti-PE microbeads 
(Miltenyi Biotec). Average purity of eosinophils from this procedure was >93%. After 
washing twice with PBS, 5 × 106 eosinophils were resuspended in 200 µl sterile PBS 
and injected i.v. into ΔdblGATA mice every 48 h for 6 days, beginning 5 days post 
oral infection. 
 
Microarray-based expression profiling and analysis of Gene Ontology 
enrichment 
Diaphragms from Rag1-/- mice were harvested at 0, 2 and 7 days post-injection 
of NBL and preserved in RNAlater (Qiagen). Individual, whole diaphragms were 
homogenized using a rotor-stator and RNA was isolated using the RNeasy Plus kit 
(Qiagen). Biotin-labeled complementary RNA (cRNA) was generated using the 
Illumina TotalPrep RNA amplification kit (Ambion). Illumina MouseWG-6 version 2 
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expression beadchips were hybridized with cRNA from three diaphragms collected on 
2 and 7 days post-injection. Two diaphragms were collected from Rag1-/- uninfected 
mice. Scanned images were converted to raw expression using GenomeStudio v1.8 
software (Illumina). Data analysis was carried out using the statistical computing 
environment, R (v3.0.2). Raw data was background subtracted, variance stabilized and 
normalized by robust spline normalization using the Lumi package (17). Differentially 
expressed genes (≥2-fold, P<0.05) were identified by linear modeling and Bayesian 
statistics using the Limma package (18). Clusters of co-regulated genes were 
identified by pearson correlation using the hclust function of the stats package in R. 
Gene Ontology enrichment analysis was conducted in the Database for Visualization 
and Integrative Discovery (DAVID) (19).  
 
Immunohistochemistry 
Immunohistochemistry was conducted as described previously (20). Rabbit 
polyclonal anti-GLUT4 antibody (Novus Biological), rabbit monoclonal anti-phospho-
Akt (Ser473, Cell Signaling) and anti-total Akt (Cell Signaling) antibodies were used. 
Sections were examined and photographed on a BX51 microscope fitted with DP-12 
digital camera system (Olympus, Melville, N.Y.). 
 
Statistical analysis 
All experiments were performed twice with similar results. Means ± SD were 
calculated from data collected from individual mice unless otherwise indicated. 
Significant differences were determined using Student’s t test or one-way ANOVA 
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with Tukey’s post hoc test for multiple means. Statistical analysis was performed with 
GraphPad Prism 5 software.  
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Results:  
 
Larval growth is regulated by IL-4/STAT6 signaling pathway  
Our previous studies showed that the reduced numbers of Th2 cells in T. 
spiralis infected muscle in eosinophil-ablated mice were associated with compromised 
larval growth. To further dissect the interaction between Th2 immunity and larval 
development, we first synchronously infected STAT6-/- mice with newborn larvae. 
Larval growth was impaired in the absence of STAT6 (Fig. 4.1. A); however, larval 
survival was not affected (Fig. 4.1. D), suggesting STAT6 signaling is essential for 
parasite growth but is not required for the IL-10 dependent protection of larvae from 
NO. IL-4 and IL-13 signal via the STAT6 pathway. Larval burdens were increased in 
orally infected Il-13 mice due to the prolonged period of intestinal colonization by 
adult worms (data not shown). Intravenously infected IL-13-/- mice supported larval 
growth normally (Fig. 4.1. C and F). In contrast, growth of larvae in IL-4-/- mice was 
impaired while larval survival was normal (Fig. 4.1. B and E). The results provide 
further evidence that larval growth and survival are controlled by distinct mechanisms, 
and show that IL-4 and STAT6 are essential for larval growth.   
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Figure 4.1. IL-4/STAT6 signaling pathway is essential for larval growth. Area of 
larvae recovered from (A) – (C), C57BL/6, STAT6-/-, IL-4-/- and IL-13-/- mice injected 
25,000 NBL intravenously. Total body larval burdens in muscles of (D) WT and 
STAT6-/- and (E) WT and IL-4-/-, 24 days post injection, and (F) WT and IL-13-/- mice 
infected orally with 300 L1, 28 days post infection. Each data set was collected from 
two experiments with similar results. Values represent mean ± SD; n = 4 mice. 
Significant differences were determined by Student’s t test. ***p < 0.0001. 
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STAT6 signaling in bone marrow-derived cells regulates larval growth 
To further examine STAT6-dependent larval growth, we infected bone marrow 
chimeric mice prepared from B6.SJL and STAT6-/- mice. The results showed that only 
mice with STAT6 competent bone marrow were able to support larval growth (Fig. 
4.2). Thus, larval growth is dependent on STAT6 signaling in bone marrow-derived 
cells and is unlikely to involve STAT6 signaling in infected skeletal muscle cells.  
 
IL-4/STAT6 signaling in eosinophils promotes larval growth 
Transfer of eosinophils isolated from either infected IL-5Tg+ or IL-5Tg+ 
/STAT6-/- mice to infected ΔdblGATA mice (5-9 dpi) improved larval burdens (Fig. 
4.3. A); however, only recipients of STAT6+/+ eosinophils supported larval growth 
(Fig. 4.3. B). Similarly, transfer of IL-4-/- eosinophils isolated from infected IL-5Tg+/ 
IL-4-/- mice did not improve larval growth in ΔdblGATA mice (Fig. 4.3. C). Thus, 
STAT6 signaling in eosinophils and eosinophil-derived IL-4 are required for parasite 
growth.  
 
Eosinophils support larval growth independently of adaptive immunity 
Larvae grew normally in Rag1-/- mice, while larval growth was impaired in 
PHIL/Rag1-/- mice (Fig. 4.4. A), indicating that eosinophils promote larval growth in 
an innate context. Type 2 innate lymphoid cells (ILC2) are IL-5 producers that can 
promote recruitment and activation of eosinophils. We questioned whether ILC2 
contributed to larval growth by recruiting and activating eosinophils. We found that  
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Figure 4.2. STAT6 signaling in bone marrow-derived cells is essential for parasite 
growth. B6.SJL and STAT6-/- mice were reconstituted with bone marrow cells from 
B6.SJL or STAT6-/- mice for eight weeks, then infected by intravenous injection of 
25,000 NBL. Areas of larvae were estimated, 13 days post injection. Each data set was 
collected from two experiments with similar results. n = 4 mice. Significant 
differences were determined by ANOVA and Tukey’s test. ***p < 0.0001. 
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Figure 4.3. IL-4/STAT6 signaling in eosinophils is required for larval growth. (A) 
– (B), ΔdblGATA mice received PBS or 5 × 106 eosinophils from infected IL-5Tg+ or 
IL-5Tg+/STAT6-/- mice every 48 h from 5 – 9 dpi. (A) Total body larval burdens in 
muscle, 28 dpi. (B) Body size (area) of larvae, 17 dpi. (C) ΔdblGATA mice received 
PBS or 5 × 106 eosinophils from infected IL-5Tg+ or IL-5Tg+/IL-4-/- mice every 48 h 
from 5 – 9 dpi. Body size (area) of larvae, 17 dpi. Each data set was collected from 
two experiments with similar results. Values represent mean ± SD; n = 4 mice. 
Significant differences were determined by ANOVA and Tukey’s test. *p < 0.05, **p 
< 0.001, ***p < 0.0001. 
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larval growth was normal in ILC2-ablated Rag2-/-γc-/- mice (Fig. 4.4. B) and 
furthermore, that recruitment of eosinophils to infected muscle was normal in the 
absence of ILC2 (14). Thus, eosinophils regulated larval growth in an innate context 
that was independent of ILC2.   
 
Identification of transcriptional changes induced by NBL infection 
To further investigate the mechanism of eosinophil-mediated larval growth in 
skeletal muscle, we performed whole genome microarray analysis to identify genes 
whose expression is altered in diaphragms during infection. We compared uninfected 
with infected Rag1-/- mice at 2 time points following intravenous infection with NBL. 
434 genes that were differentially expressed in response to infection were identified. 
Hierarchical clustering revealed four distinct clusters of co-regulated genes (Fig. 4.5. 
A). Cluster 1 includes genes that are induced at 2 dpi but which are more strongly 
upregulated later in infection. Functional enrichment analysis, carried out using 
DAVID, revealed that this cluster included genes involved in antigen presentation, 
acute immune activation and cellular remodeling (Fig. 4.5. B). Cluster 2 was 
comprised of genes specifically upregulated only at 7 dpi and largely involved in 
wound healing, cellular remodeling, and growth factor binding, consistent with 
substantial muscle cell hypertrophy and initiation of a nurse cell transformation by this 
time point (Fig. 4.5. B). Cluster 2 also included collagen IV, a major component of the 
nurse cell capsule. In contrast, cluster 3 is an early response profile that incorporates 
genes robustly expressed at 2 dpi, but not at 7 dpi. This gene set was  
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Figure 4.4. Eosinophils promote larval growth in an innate context. (A) – (B), 
C57BL/6, PHIL, Rag1-/-, PHIL/Rag1-/- and Rag2-/-γc-/- mice were injected with 25,000 
NBL intravenously. (A) Body size (area) of larvae recovered from indicated strains 13 
days post injection. (B) Body size (area) of larvae recovered from Rag1-/- and Rag2-/-
γc-/- mice, 13 days post injection. Each data set was collected from two experiments 
with similar results. Values represent mean ± SD; n = 3 - 4 mice. Significant 
differences were determined by Student’s t test or ANOVA and Tukey’s test. ***p < 
0.0001. 
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highly enriched for STAT1-inducible targets, including the immune activated 
GTPases, Gbp2, 3 and 6, Igtp1, Igtp2 and Irgm (Fig. 4.5. B). Finally, Cluster 4 is 
unique in that it represents genes that are repressed during infection, and is enriched 
for genes involved in striated muscle cell development (e.g. myosin; myh4 and 
myocyte enhancer factor; mef2c) as well as fatty acid metabolism (Fig. 4.5. B). Thus, 
transcriptional changes indicated that infection of NBL induces the loss of myofibers 
that is observed in infected cells, a strong regenerative response with transient 
induction of STAT1-dependent genes, and a shift in the source of energy in infected 
tissue.  
 
Evidence of enhanced glucose uptake in nurse cells  
The downregulation of genes involved in fatty acid metabolism suggested a 
shift to glucose metabolism. Total Akt was detected in a variety of cell types in 
sections of tongues, while phospho-Aktser473 was specifically detected at high levels in 
nurse cells (Fig. 4.6. A), consistent with active glucose metabolism in nurse cells. 
Furthermore, intracellular GLUT4 was dramatically increased and reorganized to be 
associated with vesicle-like structures in nurse cells, also supporting active transport 
of glucose (Fig. 4.6. B). These results indicated that the nurse cell is an active 
metabolic complex that serves as a nutrient-rich site for the development of muscle 
larvae.    
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Figure 4.5. Regulation of gene expression in diaphragms of infected Rag1-/- mice. 
Microarray-based gene expression profiling of diaphragms of uninfected and infected 
Rag1-/- mice on 0, 2 and 7 days post injection. (A) Heatmap shows hierarchical 
clustering analysis 434 genes differentially regulated upon NBL infection (2-fold 
differentially expressed, P ≤ 0.05). Four distinct clusters of co-regulated genes are 
indicated (colored bars left of heatmap). Color pattern represents row Z-score. (B) 
Functional enrichment results on 7 days post injection time point were carried out 
using DAVID.   
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Figure 4.6. Nurse cells upregulate GLUT4 and phosphorylation of Akt. Detection 
of (A) Akt, phospho-AktSer473 and (B) GLUT4 in tongues collected from Rag1-/- mice 
infected by intravenous injection with NBL, 13 dpi. Arrows indicate nurse cells and 
arrowheads indicate muscle larvae. Scale bar = 100µm. n = 3 mice.   
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Discussion: 
Parasitic worms are highly adapted to their hosts in ways that allow them to 
evade and even utilize host immune responses for their own purposes. Previous studies 
showed that the development of schistosomes require host CD4+ T cells (2, 3). Other 
reports show that filarial parasites regulate their development and reproduction in 
response to the induction of eosinophilia (8) and that survival and growth of T. spiralis 
requires the presence of eosinophils (4, 6, 14). We have reported previously that 
eosinophils promote muscle larvae survival by initiating CD4+IL-10+ responses that 
inhibit local nitric oxide production (4, 6, 14, 22). Results from previous studies 
indicated that eosinophil support of larval growth appeared to be regulated by a 
distinct, yet undefined mechanism (14). 
Our results demonstrate that eosinophil-derived IL-4 is essential for the normal 
development of muscle larvae. Recent studies have linked eosinophils to skeletal 
muscle regeneration, showing that eosinophils are the dominant IL-4 producing cells 
in response to muscle damage, and that IL-4 further activates the regenerative 
responses (10). Gene expression consistent with muscle regeneration feature in the 
response to NBL invasion. We speculate that eosinophils contribute to IL-4 dependent 
muscle regeneration in response to injury caused by migratory NBL. A previous report 
suggested that IL-4 secreted by regenerating myofibers stimulates IL-4Rα+ myoblast 
fusion and muscle fiber growth (23). However, our chimera experiments indicated 
STAT6 signaling in skeletal muscle cells is not essential for larval growth. Thus, 
myoblast fusion mediated muscle regeneration is unlikely to be important for nurse 
cell formation and larval growth. STAT6 signaling in bone marrow derived cells was 
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required for larval growth. Relevant to this finding is the report that IL-4Rα+ 
fibro/adipocyte progenitors (FAP) respond to eosinophil-derived IL-4 and support 
myogenesis (10). The role of FAP and other bone marrow-derived cells in the 
response to eosinophil-derived IL-4 during T. spiralis infection merits further 
investigation.  
After invading muscle cells, NBL establish an intracellular infection. 
Intracellular infection could trigger an innate defense mechanism, autophagy, which 
causes elimination of intracellular microbes (24). Autophagy is also involved in 
maintaining skeletal muscle mass and regulating glucose homeostasis in muscle cells 
(25, 26). Moreover, autophagic elimination of intracellular pathogens can be inhibited 
by Th2 cytokines, such as IL-4 and IL-13 (24). In addition to being a potent Th2 
activator, helminth products can induce autophagy (27). As we observed reduced 
numbers of Th2 cells in eosinophil-ablated mice, we speculated that T. spiralis might 
induce the recruitment of IL-4 secreting eosinophils to sites of infection to prevent 
destruction of NBL by autophagy. However, gene expression array analysis did not 
show any significant regulation of autophagy-related genes (for example, LC3a and b). 
Furthermore, we examined developing nurse cells by transmission electron 
microscopy, and no formation of an autophagosome membrane was observed in 
infected muscle cells (Huang, Appleton, and Russell, data not shown). Thus, 
autophagy is not likely to play a role in regulating larval growth in skeletal muscle.              
T. spiralis larvae store large quantities of glycogen. In the absence of 
exogenous glucose, under aerobic or anaerobic conditions, larvae rapidly break down 
endogenous stores of glycogen (28). Importantly, reduced larval glycogen correlates 
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with the impaired infectivity (29). Indeed, we found that mature larvae surviving in 
eosinophil-ablated mice were less infectious than larvae from WT mice (6), indicating 
a reduction of glycogen storage in muscle larvae when eosinophils are absent. In 
addition, it has been reported that nurse cells transport greater quantities of glucose 
than skeletal muscle cells (30). Other reports show that infection of T. spiralis induces 
host hypoglycemia and suggest that this is the result of an increase in glucose uptake 
by infected muscle cells via up-regulation of insulin signaling pathway (31). Recent 
reports demonstrated that IL-4 producing eosinophils are capable of promoting insulin 
sensitivity in adipose tissues (9, 12). The engagement of IL-4 with its receptor 
activates PI3K/Akt pathway and further promotes insulin stimulated glucose uptake in 
skeletal muscle via GLUT4 translocation (32). We therefore speculate that eosinophil-
derived IL-4 promotes muscle larval growth by enhancing glucose uptake in infected 
muscle cells.  
Inflammation has been shown to attenuate insulin sensitivity in multiple tissues 
(33, 34) IFN-γ attenuates insulin sensitivity via sustained activation of the STAT1 
pathway (35). Our array analysis revealed the activation of the STAT1 pathway 
(Cluster 3). Furthermore, activation of STAT1 appears to be sustained in eosinophil-
ablated mice (data not shown). The results support a model that eosinophil-derived IL-
4 limits STAT1 signaling, and enhances muscle cell glucose uptake, which in turn 
promote larval growth. Alternatively, STAT6 signaling in bone marrow-derived cells 
is essential for larval growth. Thus, it is possible that bone marrow-derived cells, other 
than eosinophils, are also involved in suppressing local inflammation. Bone marrow-
derived, IL-4Rα+ CD11b+ myeloid effector cells are capable of limiting excessive 
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inflammation via IL-4 induced STAT6 signaling (36). Such cells provide another 
target for eosinophil-derived IL-4 to prevent excessive inflammation and promote 
glucose uptake in skeletal muscle cells.       
Our results uncover a novel function of eosinophils in helminth infections 
revealing an unexpected mechanism in which parasitic worms co-opt innate immunity 
and host metabolism to facilitate their life cycle. By targeting and manipulating 
helminth metabolism, our finding implicates new strategic approaches for 
development of novel treatments for helminth infections.   
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Eosinophilia is a hallmark of the host immune response to helminth infection. 
The creation of two eosinophil deficient mouse models has transformed the study of 
eosinophils (1, 2). We applied two mouse models, PHIL and ΔdblGATA, towards 
investigating the roles of eosinophils in infection by the parasitic nematode Trichinella 
spiralis.        
 Previously, we showed that in the absence of eosinophils, T. spiralis muscle 
larvae die in a large numbers via a nitric oxide (NO)-mediated killing mechanism (3, 
4). The death of larvae is associated with reduced CD4+IL-4+ T cells, classical 
activation of local macrophages (M1), and increased production of NO by M1 
macrophages and neutrophils. Larval growth is also impaired in eosinophil-ablated 
mice, and restoring eosinophils improves both larval survival and growth (4). In this 
dissertation, I investigated the mechanisms underlying eosinophil-dependent larval 
survival and growth. I also investigated the role of eosinophils in secondary infection 
of T. spiralis. I found a distinct influence of eosinophils in each of these three contexts 
(Fig. 5.1). 
 Our previous studies have shown that CD4+IL-10+ T cells are responsible for 
limiting production of NO in muscle (5, 6). The numbers of muscle larvae are reduced 
in IL-10-/- mice (7) and we addressed whether eosinophils induce CD4+IL-10+ 
response. We first confirmed the importance of NO in killing by infecting 
Arg1flox/flox;Tie2cre mice, in which Arginase 1 is knocked out in myeloid cells (8). The 
reduced muscle larvae burdens correlated with the increased NO production, 
confirming a role for NO producing myeloid cells in larval clearance. Adoptive  
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Figure 5.1. Functional versatility of eosinophils in Trichinella infection. In primary 
infection, Trichinella induces a mixed Th1 and Th2 immune response associated with 
eosinophilia in skeletal muscle. By secreting IL-10, eosinophils promote the expansion 
of IL-10 producing myeloid DCs, and enhance the production of IL-10 by CD4+CD25- 
T cells. The production of NO by IFN-γ activated iNOS+ macrophages and neutrophils 
is suppressed by IL-10, thereby promoting survival of muscle larvae. In secondary 
infection, eosinophils cooperate with antibodies and/or complement to interfere with 
migratory NBL. Eosinophil peroxidase (EPX), major basic protein (MBP), eosinophil 
cationic protein (ECP) and eosinophil extracellular traps (EETs) may be involved in 
killing or impeding of NBL. Intrinsic STAT6 signaling of eosinophils and eosinophil-
derived IL-4 promote larval growth independently of adaptive immunity. Eosinophils 
may suppress activation of STAT1, which could attenuate insulin sensitivity and 
impair glucose uptake in infected muscle cells.  Dashed lines indicate potential 
mechanisms that are unproven.  
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transfer of CD4+IL-10-/- T cells to eosinophil-ablated mice improved larvae burdens, 
indicating that eosinophils promote larval survival by regulating T cell responses.  
 Eosinophils may regulate T cell responses either by acting as antigen 
presenting cells or by influencing functions of dendritic cells (9-12). We observed 
improved larval survival and growth by adoptive transfer of MHCII-/- eosinophils to 
ΔdblGATA mice, indicating antigen presentation by eosinophils is dispensable in this 
process. In contrast, the numbers of CD11b+ myeloid dendritic cells are reduced in the 
absence of eosinophils, and transfer of eosinophils restored this population. Moreover, 
transfer of bone marrow-derived myeloid dendritic cells improved larval survival and 
the numbers of CD4+IL-10+ T cells. Production of IL-10 intrinsic to myeloid dendritic 
cells is essential for development of CD4+IL-10+ T cells. Future studies will determine 
how eosinophils influence myeloid dendritic cells, specifically, how eosinophils 
promote expansion of IL-10+ myeloid dendritic cells and shift their cytokine profile.       
 Eosinophils were rapidly and specifically recruited to sites of infection in 
response to entry by NBL. Early recruitment is required for larval survival, indicating 
that eosinophils engage local immune responses at the initiation of muscle infection. 
Levels of IL-5, KC and RANTES in serum were increased, suggesting that those 
mediators are responsible for recruitment of eosinophils, although we did not discover 
the cellular source of those mediators. Type 2 innate lymphoid cells (ILC2) are not 
involved in this process, as larval survival and recruitment of eosinophils to muscle 
are normal in ILC2-ablated mice. We speculate that endothelial cells and/or tissue 
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resident mast cells may be important for this rapid release of mediators (13-16). Future 
study will examine eosinophil recruitment in mast cell deficient mice.  
 Eosinophil-derived IL-4 is not required for larval survival; however, T. spiralis 
infection induces production of IL-10 in eosinophils, which is required for CD4+IL-
10+ T cell response and larval survival. IL-10 can promote dendritic cell maturation 
(17, 18). Future study will determine whether eosinophil-derived IL-10 is required for 
the recruitment and IL-10 production in myeloid dendritic cells.  
 The mechanism that induces eosinophils to make IL-10 remains unclear. IL-6 
and IL-27 have been shown to promote IL-10 responses in T cells (17, 19-23). Results 
of our pilot study conducted in IL-27R-/- mice supported only a partial role for IL-27R 
signaling in promoting IL-10 production in eosinophils. Further investigation of the 
roles of IL-27 and IL-6 in T. spiralis infection is merited. 
    We went on to investigate the role of eosinophils in secondary infection by T. 
spiralis. Previous studies by others using either anti-IL-5 antibody or IL-5-/- mice to 
deplete eosinophils yielded contradictory results (24, 25). Our results demonstrated 
that eosinophils are dispensable for intestinal immunity against either primary or 
secondary T. spiralis infection. In contrast, eosinophils are required for preventing the 
accumulation of muscle larvae in secondary infection, an impact that is opposite to 
that observed in primary infection. Although we observed impaired memory Th2 
responses in eosinophil-ablated mice, memory responses were not to be essential for 
protection in muscle. Nevertheless, eosinophil-derived IL-25 has been reported to 
influence memory cells (26) and T. spiralis infection affords an opportunity to explore 
this mechanism.   
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 Transfer of eosinophils to previously infected ΔdblGATA mice conferred 
protection against secondary infection. Moreover, transfer of eosinophils and immune 
serum to naïve mice was protective. These results indicated that eosinophils, and most 
likely antibodies, are required for protection. Further investigation is needed to 
determine which antibody isotype is essential, and whether complement is involved.  
 The mechanism of eosinophil-mediated protection remains to be determined. 
Although MBP and EPX are capable of killing T. spiralis in vitro (27-29), results of 
pilot studies indicated that MBP-/- and EPX-/- mice were similar to WT mice in 
resisting secondary infection. Other granule proteins, such as ECP may be important 
(30).  In addition, an alternate, less direct mechanism may be at work. Recent studies 
indicate that antibodies are capable of cooperating with basophils or alternatively 
activated macrophages to impede the mobilization of larvae (31, 32). Thus, it is 
possible that eosinophils trap NBL in the presence of antibodies to prevent 
colonization of muscle. This hypothesis needs to be addressed. Furthermore, 
extracellular traps released by neutrophils and macrophages are capable of killing 
parasitic larvae (33). Eosinophils can also be activated to released extracellular traps 
that are comprised of DNA fibers and eosinophil granule proteins (34). Therefore, 
eosinophil-derived extracellular traps could be involved in secondary infection of T. 
spiralis. All of these hypotheses are testable in vitro or in vivo.  
 The last part of the dissertation addressed the mechanism of eosinophils in 
promoting muscle larvae growth, a distinct mechanism that is independent of 
eosinophil-derived IL-10. Results of larval growth inhibition and killing of T. spiralis 
in knockout mice have been summarized in Table 5.1. Our results indicate that 
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eosinophils promote larval growth independently of adaptive immunity. Eosinophil-
derived IL-4 and intrinsic STAT6 signaling are necessary to the mechanism. Adoptive 
transfer of IL-4-/- or STAT6-/- eosinophils to PHIL/Rag1-/- mice will confirm the 
dependence of growth on eosinophil-derived IL-4. Microarray analysis supported a 
model in which eosinophil-derived IL-4 enhances insulin sensitivity and the glucose 
uptake of nurse cells. Thus, further study will compare the activation of insulin 
signaling pathway between infected muscles of Rag1-/- and PHIL/Rag1-/- mice. 
Sustained activation of that STAT1 pathway was observed in eosinophil-ablated mice, 
suggesting that excessive inflammation may attenuate the insulin sensitivity in nurse 
cells, which in turn impairs larval growth. Future work will confirm the microarray 
data, and adoptive transfer experiments will be performed to confirm that eosinophil-
derived IL-4 is capable of inhibiting activation of STAT1 and improving insulin 
sensitivity in infected muscle cells.  
 The mouse model has proven to be a powerful tool for advancing our 
understanding of the function of eosinophils. Nevertheless, extrapolation of our 
findings to human disease requires care because there are differences between human 
and mouse eosinophils (35). A recently developed humanized mouse model may 
prove useful for functional study of human eosinophils (36). In summary, the data 
presented in this dissertation provide evidence that at different stages of infection, a 
particular parasitic worm may be dependent upon, susceptible to, or unaffected by 
effector functions of eosinophils. Studying of helminth infections in mice is invaluable 
to advancing our understanding of the dependency of a parasite on its host, and will 
lead to the new therapeutics and prophylactic approaches to disease control.
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Strain Growth 
inhibition 
Killing 
PHIL 52% 75% 
ΔdblGATA 33% 50% 
IL-10-/- NS 50% 
Arg1Tie2Cre NS 44% 
IL-13-/- NS NS 
IL-4-/- 32% NS 
STAT6-/- 27% NS 
Rag1-/- NS NS 
Rag2-/-γc-/-  NS NS 
PHIL/Rag1-/- 35% N/A 
 
Table 5.1. Results of larval growth inhibition and killing of T. spiralis in knockout 
mice. NS = not significant; all other values p < 0.05 or less compared to control mice. 
N/A = not available.  
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APPENDIX A 
 
The TLR2 agonist Pam3CSK4 as an immune adjuvant to treat experimental 
cutaneous leishmaniasis in mice* 
                                                 
* Lu Huang, Meleana Hinchman and Susana Mendez.  
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Abstract  
Cutaneous leishmaniasis caused by Leishmania major is an emergent, 
uncontrolled public health problem and there is no vaccine. A promising prophylactic 
approach has been immunotherapy with Toll-like receptor (TLR) agonists to enhance 
parasite-specific immune responses. We have reported that vaccination of C57BL/6 
mice with live L. major plus the TLR9 agonist CpG DNA prevents lesion 
development and confers immunity to reinfection. Our current study aims to 
investigate whether other TLR agonists can be used in immunotherapy against 
cutaneous leishmaniasis. We have found that live L. major plus the TLR2 agonist 
Pam3CSK4 also reduces pathology in both genetically resistant (C57BL/6) and 
susceptible (BALB/c) mouse strains. The addition of Pam3CSK4 activates dermal 
dendritic cells and macrophages to produce greater amounts of proinflammatory 
cytokines in both strains of mice. Th1 and Th17 responses were enhanced by 
vaccination in C57BL/6 mice; however, Th17 cells were unchanged in BALB/c mice. 
Another immunological difference between the two strains was the sustained influx of 
IL-17+ neutrophils found in the vaccination site only in BALB/c mice. Our data 
demonstrate that the mechanism behind vaccination with TLR agonists may be very 
different depending upon the immunological background of the host. This needs to be 
taken into account for the rational development of successful vaccines against the 
disease. This is also the first report showing efficacy of TLR2 immunotherapy in 
susceptible strains of mice using a cutaneous leishmaniasis model. 
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Introduction 
The prevalence of cutaneous leishmaniasis due to Leishmania major, a chronic 
disease leading to disfigurement and social stigmatization, is estimated to be at 2 
million cases (1). Recent data, however, demonstrate that this number is greatly 
underestimated (2). Current drugs are inadequate due to toxicity, resistance, and cost. 
A significant amount of work focused on prophylactic vaccine approaches have been 
tested in mice (Mus musculus), a species chosen because wild rodents are natural hosts 
for L. major (3). This has included the use of attenuated parasites, parasite extracts and 
leishmanial antigens. Although all these vaccine have yielded promising results in 
rodent models (4), they have failed when tested in primates or humans (5). Inoculation 
of virulent L. major (leishmanization), practiced in endemic areas for millennia, has 
been the only strategy that has ever provided protection in humans, possibly because it 
mimics a natural infection, parasite persistence, and concomitant immunity. 
Leishmanization was widely applied, but because of exacerbated skin disease reported 
in rare cases (6), the vaccine was discontinued. However, the traditional practice of 
leishmanization has made a comeback in certain endemic regions, given that it is the 
only vaccine with proven efficacy in humans.  
 Efforts to improve the safety of leishmanization have included the addition of 
killed parasites or immune adjuvants to reduce the size and duration of lesions (6). Our 
particular approach to a safer leishmanization has been to use Toll-like receptor (TLR) 
agonists. TLRs are a family of 11 transmembrane proteins that specifically recognize 
different pathogens (7). The therapeutic effects of TLR activation in immunotherapy 
are associated with the expression of high levels of IL-12 and IFN-γ. In particular the 
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use of TLR agonists as immune adjuvants in leishmaniasis have yielded promising 
results As examples, the TLR7 agonist Aldara showed anti-leishmanial activity in 
experimental models and in clinical studies of cutaneous leishmaniasis in combination 
with conventional therapy (8, 9). CpG DNA, a TLR9 agonist, has been extensively 
tested and has shown wide prophylactic and therapeutic anti-leishmania potential (10-
13). For the last past years, we have investigated a leishmanization approach 
consisting on the inoculation of live parasites along with CpG DNA (Lm/CpG). We 
showed that Lm/CpG prevents vaccinal lesions (an undesired effect of live 
vaccination) in C57BL/6 mice while achieving parasite persistence and immunity (14, 
15). Mechanistically, we found that Lm/CpG causes activation of dermal dendritic 
cells (DCs) to produce IL-6 (15), and IL-2, activation of NK cells (16), and expansion 
of Th17 responses (17).  
 Mice have remained the major model for testing the efficacy of vaccines 
against cutaneous disease. Resistance or susceptibility to L. major in this species is 
dependent on the type of CD4+ helper T cell (Th) subset that is induced. Healing in 
resistant mice (i.e. C57BL/6) is associated with the development of IFN-γ-producing 
Th1 cells. In contrast, susceptibility (e.g. in BALB/c mice) is mediated by an early IL-
4 production that promotes the development and expansion of Th2 cells (18). 
Contrasting with these highly polarized responses in mice, human infection data show 
that a mixed Th1/Th2 response is more typically observed (19). Hence, we propose 
that prospective prophylactic strategies must be evaluated in both Th1 and Th2 models 
of disease. 
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 The aim of this study is to determine whether TLR agonists other than CpG 
DNA could be use in immunotherapy to treat cutaneous leishmaniasis. Here, we have 
found that in C57BL/6 mice, L. major infection upregulates the expression of TLR2 in 
bone-marrow-derived dendritic cells. This contrasts with our data obtained using 
BALB/c mice, where there is no change in the expression of TLR2 in the same cell 
type. Interestingly however, TLR2 agonist Pam3CSK4 treatment of infected cells 
from both strains of mice results in an enhanced proinflammatory response. Because 
TLR2 agonists have been proposed as adjuvants of vaccine in other models (20-22), 
we investigated the use of Pam3CSK4 as an immune adjuvant using our 
leishmanization model. We have also found that vaccination with live L. major plus 
Pam3CSK4 completely prevents lesion development and decreases parasite burdens in 
susceptible (BALB/c) and resistant (C57BL/6) strains of mice. In both cases, dermal 
dendritic cells and macrophages express greater amounts of pro-inflammatory 
cytokines. Both Th1 and Th17 responses were enhanced in C57BL/6 mice, 
conversely, Th17 responses were not enhanced in BALB/c mice in the presence of 
Pam3CSK4. However, neutrophils responses were enhanced and sustained in the 
susceptible mice. 
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Materials and Methods 
Mice 
Six-week-old C57BL/6 and BALB/c mice were purchased from Taconic and 
The Jackson Laboratory, respectively. All mice were maintained in the Baker Institute 
for Animal Health animal care facility under pathogen-free conditions. All animal 
experiments were performed according to federal guidelines and institutional policies. 
 
Parasites 
L. major clone V1 (MHOM/IL/80/Friedlin) promastigotes were grown at 26 °C 
in medium 199 supplemented with 20% heat-inactivated fetal calf serum (FCS) 
(Gemini, Sacramento, CA), 100 U/ml penicillin, 100 mg/ml streptomycin, 2 mM L-
glutamine, 40 mM HEPES, 0.1 mM adenine (in 50 mM HEPES), and 5 mg/ml hemin 
(in 50% triethanolamine).  
 
Infection protocol and vaccine preparation 
Infective-stage promastigotes (metacyclics) of L. major were isolated from 
stationary cultures (4-5 days old) by Ficoll enrichment as described before(23). Mice 
were vaccinated intradermally in both ears with 106 L. major promastigotes alone or 
mixed with 50 µg (in DMEM) of a single TLR2 agonist, the synthetic triacylated 
lipopeptide Pam3CSK4 (InvivoGen, San Diego, CA), using a 27G needle in a volume 
of 10 ml.  
 
Parasite titration 
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Parasite loads in the ears were determined as described before (24). Briefly, the 
ear sheets were separated and deposited in DMEM containing Liberase CI enzyme 
blend (0.5 mg/ml) for 60 min at 37 °C. The sheets were then dissociated using a 
handheld tissue homogenizer. The homogenates were filtered using a 70-mm cell 
strainer (BD Falcon, San Jose, CA) to produce single cell suspensions and serially 
diluted in a 96-well flat-bottom microtiter plates containing biphasic medium prepared 
using 50 mL Novy-MacNeal-Nicolle (NNN) medium containing 20% of defibrinated 
rabbit blood overlaid with 100 mL M199. The number of viable parasites in each ear 
was estimated by limiting dilution from the highest dilution at which promastigotes 
could be grown out after 7 days of incubation at 26 °C. Parasite numbers were also 
determined in the local draining lymph node (submandibular). Lymph nodes were 
mechanically dissociated and parasite load was determined by limiting dilution as 
described above. 
 
Preparation of soluble Leishmania antigen 
Thirty mL of stationary phase cultures (4-6 days old) were taken in a 50-ml 
tube and centrifuged at 3,500 rpm for 15 min at CT. The resulting pellets were washed 
three times with cold 0.02 M PBS (pH 7.2) subjected to three cycles of freezing and 
thawing, and centrifuged at 10,000 rpm for 20 min. Supernatant was collected, and 
protein estimation was done by BCA assay following the manufacturer’s 
recommendations. Protein samples were stored at -80 °C until use. 
 
Cell analysis from ears and draining lymph nodes 
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Single-cell suspensions from the ear dermis were obtained as described above. 
For the analysis of surface markers and intracytoplasmic staining for cytokines, single 
cell suspensions obtained from ears and draining lymph nodes (as described above) 
were stimulated overnight with 25 mg/mL soluble Leishmania antigen, 5 ng/mL IL-2 
and 10 mg/mL anti-CD28, and then cultured with brefeldin A at 10 ng/ml for 6 h and 
then fixed in 4% paraformaldehyde (24). Prior to staining, cells were incubated with 
an anti-Fcg III/II receptor antibody and 10% normal mouse serum in PBS containing 
0.1% BSA, 0.01% NaN3. Cells were permeabilized and stained for the surface markers 
CD4 (clone RM4-5), CD11c (clone N418), Ly-6G (Gr-1, clone 1A8) and F4/80 (clone 
BM8), for the cytokines IL-6 (clone MP5-20F3), IL-12/IL-23p40 (clone C17.8), IL-4 
(clone 11B11), IL-10 (clone JES5-16E3), IL-17A (clone TC11-18H10.1) and IFN-γ 
(clone XMG1.2). Incubations were carried out for 30 min on ice. For each sample, at 
least 50,000 cells were analyzed. The data were collected and analyzed using 
CellQuest software and a FACSCalibur flow cytometer (Becton Dickinson, San Jose, 
CA). 
 
Bone marrow-derived dendritic cells and macrophage culture 
Bone marrow-derived dendritic cells (BMDDCs) were generated as described 
(25). In brief, bone marrow cells from C57BL/6 mice or BALB/c mice were isolated 
by flushing femurs and tibiae with RPMI 1640. After treatment with ACK buffer to 
lyse red blood cells, bone marrow cells were cultured in complete RPMI 1640 
supplemented with 20 ng/ml recombinant murine granulocyte-macrophage colony-
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stimulating factor (GM-CSF). Fresh cell culture medium was added on day 3 and day 
6. After 9 days, floating cells were used as immature BMDDCs.  
 Bone marrow-derived macrophages (BMDMs) were generated as also as 
described before (25). Briefly, bone marrow cells from C57BL/6 mice or BALB/c 
mice were isolated as described above and cultured in complete DMEM supplemented 
with 20% L-929-conditioned medium, which contains granulocyte colony-stimulating 
factor (G-CSF). Fresh cell culture medium was added on day 5. After 7 days, BMDMs 
were ready to use. 
 
In vitro macrophage and dendritic cell infection and surface TLR2 expression 
analysis 
 
Infective-stage promastigotes (metacyclics) of L. major from Ficoll enrichment 
were washed three times in PBS, resuspended at 20 × 106/ml in PBS, and incubated 
with 5 mM 5 (6)-carboxyfluorescein diacetate succinimidyl ester (CFSE) for 15 min at 
37 °C. Depending on the experiment, BMDDCs or BMDMs were infected for 18 h 
with unlabeled or CFSE-labeled parasites at a cell/parasite ratio of 1:5. Cells were also 
treated with 0.5 mg/ml of the TLR2 agonist Pam3CSK4, either at the time of 
infection, or at 18 h post infection.  
Eighteen hours post infection, supernatants were collected for cytokines 
analysis and cells were harvested for surface TLR2 expression analysis. To determine 
surface TLR2 expression, free parasites were washed away from BMDDCs culture by 
washing three times with cold PBS. Cells were then harvested, incubated with an anti-
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Fcg III/II receptor antibody and 10% normal mouse serum in PBS, and then stained 
for expression of the surface markers CD11c (clone N418) and TLR2 (clone 6C2).  
 
Cytokine measurements 
Cytokine IL-12p40/p70 in the supernatants from in vitro stimulation was 
measured by c sandwich ELISA as described (24). All antibodies were purchased from 
BD Bioscience. 
 
RNA extraction and real-time PCR analysis 
Total RNA from BMDDCs uninfected or infected with L. major was extracted 
using TRIzol reagent.  Reverse transcription of the RNA (1 mg) was performed using 
SuperScript III First-Strand Synthesis System (Invitrogen, Carlsbad, CA). Real-time 
PCR was performed in the Applied Biosystems 7500 real-time PCR system. The 
reaction was performed using the FAST SYBR Green master mix (Applied 
Biosystems, Carlsbad, CA). β-actin was used as internal control for each sample. The 
primers used were as follows: TLR2 forward, 5’-CTCTGTCATGTGATGCTTCTG-
3’; TLR2 reverse, 5’-ATGTTACCCCCAGTGTCTGG-3’; β-actin forward, 5’- 
GCTCCGGCATGTGCAA-3’; β-actin reverse, 5’-AGGATCTTCATGAGGTAGT-3’. 
 
Statistical analysis 
All comparisons of non-normally distributed continuous data were analyzed 
with Student t-test, Mann-Whitney test or ANOVA with Tukey’s post hoc test for 
multiple means using GraphPad Prism 5 (San Diego, CA).  
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Results 
L. major-infected bone marrow derived dendritic cells upregulate TLR2 
expression only in C57BL/6 mice 
Because it has been suggested that TLR2 interacts with L. major and triggers 
the host immune response against the parasite (26-28), we investigated changes in 
TLR2 expression in L. major-infected bone marrow-derived DCs. We carried out 
these experiments using both resistant (C57BL/6) and susceptible (BALB/c) mouse 
strains. Fig. A1 A shows that TLR2 mRNA expression was upregulated 9-fold in 
infected DCs derived from C57BL/6 mice. However, this upregulation was not 
observed in infected DCs from BALB/c mice. To confirm the genetic results, we then 
determined TLR2 protein expression in both infected and uninfected cells by flow 
cytometry. Fig. A1 B demonstrates that, in C57BL/6 mice, TLR2 was expressed in 
43% of cells from uninfected cultures. The mean intensity of fluorescence (MFI) for 
the receptor was 145.1. TLR2 cell expression was increased to 76% in the infected 
cultures; the MFI also increased to 280. To establish whether those changes in TLR2 
expression were a direct consequence of infection, we employed CFSE-labeled 
parasites to directly track the infected cells. A parasite:cell ratio of 5:1 resulted in the 
infection of more than 60% of the cells in culture (Fig. A2 A). Seventy percent of DCs 
from C57BL/6 mice containing fluorescent parasites expressed TLR2; in contrast, its 
expression was reduced to 19% in uninfected cell cultures (Fig. A2 B). As before, the 
MFI for TLR2 expression increased in the infected cells (from 158.4 to 213.7). 
 Interestingly, TLR2 expression in uninfected cells from BALB/c mice was 
significantly higher (>80%), and infection with L. major did not significantly increase  
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Figure A1. L. major-infected BMDDCs have higher expression of TLR2 only in 
C57BL/6 mice. (A). TLR2 mRNA transcript level measured by real-time PCR 
analysis post infection. Data are normalized to β-actin, and show mean ± SEM (n = 5 
different experiments). Surface TLR2 expression of BMDDCs from (B) C57BL/6 and 
(C) BALB/c measured by flow cytometry. Grey histogram, unstained; dotted line, 
uninfected; solid line, L. major-infected cells. Mean fluorescence intensity (MFI) and 
Coefficient of Variation (CV) values are include in the figure. Data are representative 
of n = 3 experiments with similar results. Asterisks indicate statistically significant 
differences following Student t-test between the two groups; *p<0.05.  
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Figure A2. Infected BMDDCs upregulate TLR2 expression in the C57BL/6 
mouse. Flow cytometry plots of bone marrow-derived CD11c+ DCs from (A) 
C57BL/6 and (C) BALB/c mice infected with CFSE-labeled L. major at a cell/parasite 
ratio of 1:5. Numbers indicate relative frequencies of infected (double positive) and 
uninfected (single positive) cells. Surface TLR2 expression in the infected, double 
positive (solid line) and in the uninfected, single positive (dotted line) populations 
from (B) C57BL/6 and (D) BALB/c mice. An unstained sample is included as a grey 
histogram. MFI and CV values are also shown. Data are representative of n = 3 
experiments with similar results. 
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the receptor expression (Fig. A1 C). MFI values for TLR2 did not significantly change 
either. As expected, infection did not significantly change the already elevated 
expression of the receptor (Fig. A2 D).  
 
The TLR2 agonist Pam3CSK4 increases the ability of L. major-infected BMDDCs 
and BMDMs to secrete the pro-inflammatory IL-12 
Next we determined whether the upregulation of TLR2 expression would 
result in an enhanced response to TLR2 stimulation. We infected BMDDCs from 
either C57BL/6 or BALB/c with L. major and treated them with the TLR2 agonist 
Pam3CSK4, either at the time of infection, or later. The production of IL-12 was 
measured in culture supernatants 24 h post stimulation. Fig. A3 A shows that, as 
expected, uninfected DCs produce IL-12 in response to Pam3CSK4. This cytokine 
response was significantly greater than what was secreted following infection 
(P<0.001). Interestingly, IL-12 production was enhanced in L. major-infected cells 
treated with the TLR2 agonist, irrespective of when it was added to the cultures (at the 
time of after infection). We also determined the effect of agonist treatment in infected 
BMDMs. In this population, addition of the TLR agonist alone did not significantly 
increase cytokine production (Fig. A3 B) when compared to infected cells, conversely, 
Pam3CSK4 treatment enhanced IL-12 production in macrophages when added at the 
time of infection (P<0.02), or after infection (P<0.001). These results indicate that 
infected cells that display upregulation of TLR2 become more responsive to the effect 
of agonist treatment, enhancing proinflammatory responses. 
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Figure A3. Pam3CSK4 increases secretion of IL-12 in L. major infected BMDDCs 
and BMDMs. IL-12 production measured by ELISA 24 h post stimulation in culture 
supernatants from BMDDCs and BMDMs infected or not with L. major (Lm, 1 cell : 5 
parasites). Infected cultures were treated with 0.5 mg/ml of Pam3CSK4 at the time of 
the infection (Lm + Pam3) or after the infection (Lm + Pam3 (18h)). BMDDCs data 
are shown in (A) C57BL/6 and (C) BALB/c. BMDM data are shown in (B) C57BL/6 
and (D) BALB/c. Data show mean ± SEM (n = 5 independent experiments). Asterisks 
indicate statistically significant differences between the two groups. Significant 
differences were determined by ANOVA and Tukey’s test. *p < 0.05, **p<0.01, 
***p<0.001.  
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Pam3CSK4 treatment at the time of L. major infection prevented the 
development of lesions and decreased parasite burden in mice 
 Our in vitro data strongly suggested that the pro-inflammatory properties of 
Pam3CSK4 could enhance anti-leishmanial immunity in vivo. In order to determine 
the outcomes of Pam3CSK4 treatment, we tested our hypothesis by using two 
different strains of mice. We infected C57BL/6 mice (Th1-biased, self-healing 
disease) and BALB/c mice (Th2 biased, progressive disease) in the ears with a 
suspension of 106 L. major parasites containing or not 50 µg Pam3CSK4. We 
monitored lesion development and determined parasite burden in ears at early (day 2) 
and late (days 42 for C57BL/6 mice and 70 for BALB/c mice) time points. Fig. A4 A 
and A4 B show that all mice treated with Pam3CSK4 developed either small or no 
lesions when compared with mice infected with parasites alone (P < 0.001). 
 Parasite burden data from ears and lymph nodes of C57BL/6 mice (Fig. A4 C 
and A4 D, respectively) revealed no differences between the two experimental groups 
at the early time point (day 2). This suggests that treatment with the TLR2 agonist did 
not interfere with parasite establishment in these mice. In contrast, parasite burden was 
significantly decreased in both ears and lymph nodes of C57BL/6 at day 42 (P < 0.001 
and P < 0.01, respectively).  
On the other hand, the establishment of L. major infection in ears and draining 
lymph nodes of BALB/c mice was dramatically compromised at the early time point, 
as burdens were significantly decreased in both sites at day 2. At day 70, parasite 
burdens were still significantly lower in the ears of mice treated with Pam3CSK4, but 
no differences were detected in lymph node burdens. These results suggest that, while 
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Figure A4. Vaccination with L. major + Pam3CSK4 decreased lesion size and 
parasites burden in mice. Mice were injected in the ear dermis with 106 L. major 
alone or in combination with 50 µg Pam3CSK4. Figure shows lesion size (mm) in (A) 
C57BL/6 and (B) BALB/c mice expressed as mean ± SEM (n = 12 ears/group). 
Asterisks indicate statistically significant differences following Student t-test between 
the two groups at each time point; *p < 0.05. Parasites burden shown in C and E 
represent data from ears of C57BL/6 and BALB/c mice respectively. Parasites burden 
shown in D and F represent data from submandibular lymph nodes of C57BL/6 and 
BALB/c mice respectively. Data were collected at day 2 (both strains), 42 (C57BL/6) 
and 70 (BALB/c mice) post vaccination, and are expressed as log geometric mean ± 
SD, n = 6 ears or lymph nodes per group. Data are representative of two to three 
experiments with similar results. Asterisks indicate statistically significant differences 
following Mann-Whitney analysis between the two groups at each time point;  *p < 
0.05, ** p < 0.001.  
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Pam3CSK4 prevents the development of pathology in both mouse strains; the kinetics 
and the mechanism whereby pathology is prevented may be different.  
 
Pam3CSK4 increases the expression of dermal proinflammatory cytokines  
 We have shown that vaccination with L. major and CpG DNA increased the 
early proinflammatory cytokine production in the dermis of C57BL/6 mice (15). To 
determine if this activation mechanism caused by the TLR9 agonist is shared with 
other TLR ligands, we investigated the expression of the proinflammatory cytokines 
IL-12 and IL-6 at 48 h post vaccination, in both dermal DCs (expressing CD11c) and 
macrophages (expressing F4/80). As shown in Table A1, the total numbers of cells 
positive for IL-12 and IL-6 staining was significantly increased at 48 h in all mice 
vaccinated with parasites plus Pam3CSK4, irrespective of the mouse strain. 
Cytoplasmic IL-10 staining did not show significant differences among any of the 
groups, and the level of expression was very low (>2%) in all cases (not shown).  This 
demonstrates that vaccination with live parasites and TLR2 agonists also induces the 
early initiation of a proinflammatory response at the vaccination site.  
 
Vaccination with L. major plus Pam3CSK4 induces the expansion of Th1 and 
Th17 cells in C57BL/6 
 Our results have revealed so far that both resistant and susceptible mouse 
strains are protected against the development of lesions by Pam3CSK4 treatment. Our 
previous work with live parasites and CpG DNA revealed that Th1, but particularly  
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Table A1.  Cytokine expression at 48 h post vaccination in dermal cells of mice 
vaccinated with L. major alone or in combination with 50 µg Pam3CSK4. Data 
show average ± standard deviation of the percentage of cytokine expressing cells  (n = 
3). P values obtained from comparing both groups are included in the table. 
 
  L. major L. major+Pam3CSK4 P values 
C57BL/6     
CD11c+ DC IL-12 7.3 ± 4.0 21.4 ± 3.9  P=0.005 
 IL-6 5.8 ± 2.6 15.7 ± 6.2  P=0.06 
     
F4/80+ Macrophages IL-12 11.4 ± 1.2 32.3 ± 4.8   P=0.001 
 IL-6 5.7 ± 2.5 11.0 ± 1.2  P=0.03 
BALB/c     
CD11c+ DC IL-12 5.1 ± 1.3 11.3 ± 2.9  P=0.006 
 IL-6 4.5 ± 2.3 11.3 ± 2.7  P=0.02 
     
F4/80+ Macrophages IL-12 4.4 ± 1.2 13.1 ± 3.3  P=0.01 
 IL-6 6.1 ± 3.0 18.8 ± 2.4  P=0.004 
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Th17 responses were required to control vaccinal pathology in the C57BL/6 mouse 
(17). However, the immune response of the BALB/c mice to this vaccine has remained 
uncharacterized. To investigate whether the CpG DNA-induced Th17 cell expansion is 
shared with other TLR agonists, we determined the absolute numbers of cytokine 
producing CD4 T cells in the ear draining lymph nodes of the vaccinated mice at early 
and late time points as described before. Fig. A5 A shows that both Th17 and Th1 
responses are enhanced by vaccination with a mixture of live parasites and TLR2 
agonist in resistant mice. This enhanced CD4 response was similar to what was 
described in our previous work using CpG DNA (17). Conversely, L. major plus 
Pam3CSK4 vaccination did not enhance Th17 responses in the BALB/c strain, 
although the number of Th1 IFN-γ expressing cells was higher in the L. major plus 
Pam3CSK4-vaccinated group (Fig. A5 B); the immune response in these mice was 
dominated by Th1 cells, as opposed of what was found in the mice vaccinated with L. 
major alone.  An interesting finding was that the immune response to Leishmania 
switched from a Th2 into a Th1 in the vaccinated mice. This trend continued 
throughout the course of the infection, as demonstrated by the data obtained in the 
latest time point (Fig. A5 C and A5 D). These data suggest that the mechanisms 
underlying protection are different between both strains of mice. 
 
Pam3CSK4 induces neutrophil influx as well as a rapid IL-17 production to the 
site of vaccination  
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Figure A5. Vaccination with L. major plus Pam3CSK4 increased the number of 
Th1 and Th17 cells in C57BL/6 mice but only Th1 in BALB/c mice. Absolute 
numbers of IFN-γ (Th1 cells), IL-17 (Th17 cells), IL-4 and IL-10 producing CD4+ T 
cells shows in (A) and (C), (B) and (D) in submandibular lymph nodes of C57BL/6 
and BALB/c mice respectively. Recovered lymph node cells were restimulated with 
25 mg/mL soluble Leishmania antigen, 5 ng/mL IL-2 and 10 mg/mL anti-CD28 
overnight before performing cytokine staining. Data were collected at day 2 (both 
strains), 42 (C57BL/6) and 70 (BALB/c mice) post vaccination, and are expressed as 
mean ± SEM, n = 6 lymph nodes per group. Data are representative of two to three 
experiments with similar results. Asterisks indicate statistically significant differences 
following Mann-Whitney analysis between the two groups at each time point;  *p < 
0.05. 
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 We have reported that, in C57BL/6 mice, vaccination with live parasites and 
CpG DNA increased the influx of neutrophils to the vaccination site early after 
vaccination (17).  Fig. A6 A and B show that shortly after vaccination, neutrophils are 
significantly increased in both C57BL/6 and BALB/c, although their numbers were 
dramatically decreased at the later time point in the resistant mouse. Conversely, and 
despite the lack of pathology, neutrophil numbers remained high in the skin of 
vaccinated BALB/c mice. Because other authors have reported increasing amounts of 
IL-17 production by neutrophils in infected BALB/c (29), we assessed the ability of 
neutrophils produce IL-17 following vaccination. Although neutrophils infiltrate the 
vaccination site immediately after vaccination in in both mouse strains, there was a 
greater number of IL-17 producing neutrophils in BALB/c mice (Fig. A6 C and A6 
D). Moreover, neutrophils from BALB/c mice treated only with Pam3CSK4 also 
produce large amount of IL-17, indicating a specific effect of Pam3CSK4 on 
neutrophils in susceptible mice.  
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Figure A6. BALB/c mice showed sustained infiltration of neutrophils and rapid 
production of IL-17 after vaccination with L. major plus Pam3CSK4. Absolute 
numbers of Ly-6G+ neutrophils shows in (A) C57BL/6 and (B) BALB/c mice ears. 
Absolute numbers of dermal IL-17+ Ly-6G+ neutrophils determined by flow cytometry 
in (C) C57BL/6 and (D) BALB/c mice. Data were collected at day 2, 42 (C57BL/6) 
and 70 (BALB/c mice) post vaccination, and are expressed as mean ± SEM, n = 6 ears 
per group. Recovered ear cells were retimulated with 25 mg/mL soluble Leishmania 
antigen, 5 ng/mL IL-2 and 10 mg/mL anti-CD28 overnight before performing 
cytokine staining for IL-17. Data are representative of two to three experiments with 
similar results. Asterisks indicate statistically significant differences following Mann-
Whitney analysis between the two groups at each time point; *p < 0.05. 
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Discussion 
To date, there is no vaccine against cutaneous leishmaniasis. The major 
impediment in vaccine design has been the failure in translating data from animal 
models to human disease, as well as the lack of understanding of how protective 
immune responses and immunological memory are generated and maintained (30). In 
this paper, we have discovered that vaccination with live parasites in the presence of 
the TLR2 agonist Pam3CSK4 protects susceptible and resistant mice against the 
development of leishmaniasis, albeit the underlying immunological mechanisms 
appear to be completely different.  
Our work has focused on understanding how live vaccination immunity is 
modulated by the addition of TLR agonists. In particular, we have extensively 
characterized the immune responses of the C57BL/6 mouse to vaccination with live 
parasites plus the TLR9 agonist CpG DNA (14-17, 31, 32). We employed this mouse 
strain because, unlike the susceptible BALB/c that succumb to systemic disease by L. 
major, infection of C57BL/6 replicates all clinical features of human cutaneous 
leishmaniasis: self-healing lesions (33, 34), chronicity (35) and concomitant immunity 
(36). 
The first objective of this study was to validate the immunological mechanism 
of protection behind live vaccination with CpG DNA, and to investigate whether this 
mechanism is shared with other TLR agonists. We chose TLR2 because this is the 
most promiscuous TLR receptor, being able to recognize the most diverse set of 
pathogen-associated molecular patterns (PAMP). Furthermore, lipophosphoglycan 
(LPG), a PAMP in Leishmania, has been shown to bind to TLR2 and activate NF-κB 
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translocation in a TLR2-dependent manner. This ligation upregulates TLR2 
expression and eventually promotes the production of IFN-γ and TNF-α in NK cells 
(26, 27). Moreover, TLR2 is widely express among human leukocytes, what will 
ensure a very intense response following receptor ligation. And most importantly, we 
have shown that L. major-infected cells become more sensitive to TLR2 stimulation 
and increase their proinflammatory response. Our data demonstrate that vaccination 
with live parasites plus the TLR2 agonist Pam3CSK4 completely protected mice 
against the development of lesions, suggesting that TLR2 stimulation also results in 
enhanced anti-leishmanial immunity. Unexpectedly, we have found that expression of 
TLR in DCs is different between the two strains of mice. This result is similar with the 
previous report that expression levels of TLR2, TLR4, TLR5 and TLR6 in naïve 
splenic DCs are higher in BALB/c mice than in C57BL6 mice (37). The reactivity of 
DCs in both strains of mice is also different upon TLR ligand stimulation. Take 
together, our data suggest that difference in both expression pattern and reactivity of 
TLRs may be associated with susceptibility and resistance to L. major infection in 
C57BL/6 and BALB/c mice.  
The second objective of our work was to compare the immunological events 
associated with protection following vaccination of both genetically susceptible and 
resistant mouse strains, which are characterized by extreme Th2 or Th1 polarization, 
respectively. The immune responses to cutaneous leishmaniasis in humans lack the 
strong polarity found in mouse models. Epidemiological data from patients with 
localized cutaneous leishmaniasis seem to confirm the Th1/Th2 dichotomy shown in 
mice. However, patients with diffuse cutaneous leishmaniasis display a more 
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predominant Th2 cytokine response. Moreover, patient with mucosal leishmaniasis 
show a mixture of Th1 and Th2 cytokines (38). Thus, the comparative study of the 
mouse models is important to be able to predict how, and whether, vaccine efficacy 
studies that employ TLR2 agonists would translate to human vaccines. 
Our data showing that live vaccination with parasites plus Pam3CSK4 protects 
both C57BL/6 mice and BALB/c against lesions are very promising, and point 
towards the feasibility of the use of TLR2 agonists as immune adjuvants against 
leishmaniasis. However, our studies have also revealed that the mechanism underlying 
protection is very different between the two mouse strains. C57BL/6 mice, as we 
demonstrated before, develop a strong Th17 response following vaccination with TLR 
agonists. However, this effector population did not expand in vaccinated BALB/c 
mice; in these animals, protection was caused by enhanced Th1 responses.  
Another remarkable vaccination difference between the two strains was the 
sustained IL-17+ neutrophil influx in BALB/c, but not in C57BL/6 mice. We still do 
not have a mechanistic explanation to explain these differences. The role of the 
neutrophil is leishmaniasis is not well understood because it varies depending on the 
species of Leishmania and the animal models employed. As a few examples, studies in 
the C57BL/6 mice have shown that neutrophils may help infection by harboring 
parasites (39). But conversely, others have revealed that neutrophils contribute to 
parasite killing (40). Moreover, neutrophil influx has been associated with resistance 
or susceptibility in L. amazonensis murine models (41). Finally, neutrophils appear to 
be required for protective responses in L. braziliensis (42). Our data also uncovered an 
interesting outcome of vaccination which is at early time point, neutrophils in BALB/c 
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mice that vaccinated with live parasites plus Pam3CSK4 produce large amount of IL-
17, which may be due to the specific effect of Pam3CSK4 in this cell type only in the 
susceptible strain. Some studies have already shown the distinct phenotypes of 
neutrophils expressing different TLRs in both resistant and susceptible mice during L. 
major infection (43). Differential expression of TLRs by neutrophils may cause the 
diverse responses to TLRs agonist and thus influence the development of L. major 
specific immune response in our vaccination. We plan to define the function of 
neutrophils as well as the role of IL-17 in future studies.  
Our findings are relevant because they reveal the complexity and the difficulty 
to achieve vaccine protection: by exclusively taking into account the C57BL/6 data, 
we would have concluded that enhancing Th17 response is necessary to protect 
against leishmanial challenge. However, enhancing Th17 responses may not to work 
individuals displaying Th2 or mixed Th1/Th2 responses. Understanding the factors 
that regulate parasite persistence and its role in maintenance of immunologic memory 
in cutaneous leishmaniasis is critical for proper design and development of effective 
vaccine and vaccination strategies against the disease, and may explain why 
vaccination strategies have not translated very well from the mouse to the human. 
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APPENDIX B 
A Th-17 inducing live vaccine comprised of Leishmania major and CpG DNA does 
not induce memory Th17 cell establishment in the skin of vaccinated mice* 
                                                 
*Lu Huang, Weishan Huang, Avery August and Susana Mendez 
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Abstract 
Cutaneous leishmaniasis caused by Leishmania major is a neglected, emerging 
parasitic disease with no vaccine. We have previously demonstrated that intradermal 
vaccination of the resistant C57BL/6 mice with live parasites plus CpG DNA is highly 
effective as it eliminates disease pathology and provides long-term immunity. We 
have also reported that this strategy induces the generation of CD4+ Th17 cells in the 
dermis of the vaccinated animals, which in turn causes parasite killing and contributes 
to disease prevention in the skin. Because Th17 cells have been associated with 
several skin immune disorders, we investigated the establishment of memory Th17 
cells in the skin of mice immunized with the anti-leishmanial vaccine. Our studies 
have demonstrated that dermal memory CD4+ T cells isolated from the skin and lymph 
nodes of the vaccinated mice produce small amounts of IFN-γ, but no IL-17. 
Revaccination of these mice with the live anti-leishmanial vaccine or inoculation of 
other antigens (i.e. OVA) did not induce the expansion of IL-17 effector memory 
CD4+ T cells either. Our results demonstrate that Th17 cells induced by the 
vaccination of L. major plus CpG DNA are a transient cell population that involves in 
the early protection against infection but do not generate memory in the chronic site. 
This suggests that this is a safe approach to vaccination that can be applied to 
individuals prone to skin immune disorders involving IL-17 production. 
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Introduction 
The leishmaniases are a group of emerging, uncontrolled vector-borne parasitic 
diseases prevalent worldwide. The disease is endemic in 88 countries; 350 million 
people are at risk and 12 million people are affected (1). Recent data suggest that these 
numbers are greatly underestimated. Although the disease can be treated, current drugs 
are inadequate due to toxicity, resistance, cost and adverse effects. There is no 
vaccine. Thus, there is a clear need for both prophylactic and therapeutic control 
measures. During the past decade, our research has focused on studying the 
mechanism of action of leishmanization (live vaccination), the only strategy that has 
ever provided lifelong protection (2), by using a murine model of cutaneous disease 
(C57BL/6 mice and Leishmania major). Our vaccination approach (immunization of 
mice with live L. major parasites along with CpG DNA) reduced or completely 
eliminated disease in C57BL/6 mice without compromising long-term protection (3, 
4). We have previously demonstrated that this live vaccine enhances recruitment of 
IFN-γ-producing CD4+ T cells (4), decreases expansion of dermal regulatory T cells 
(5), causes activation of dermal NK cells (6), and most interestingly, promotes the 
local expansion of T helper (Th)-17 cells (7).  
Th17 cells are subset of CD4+ T cells that preferentially produce IL-17, IL-21, 
and IL-22 (8). Multiple evidence has accumulated for a role of Th17 cells in the 
protective response against fungi and yeast (9, 10), extracellular bacteria (reviewed in 
(11)), viruses (12, 13), and protozoa (14-16). However, and despite the beneficial 
functions of this Th cell subset in protective immunity against pathogens, IL-17 is also 
associated with human immune pathology. For example, IL-17-expressing T-cell 
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clones are reported in synovial tissues from rheumatoid arthritis patients (17, 18), and 
in the cerebrospinal fluid of multiple sclerosis patients (19). Moreover, increased IL-
17 levels are observed in sera and inflamed mucosae from patients suffering from 
Crohn's disease or ulcerative colitis (20).  
Our intradermal vaccination model has demonstrated that IL-17 may be an 
important modulator of Leishmania growth and pathology in the skin, particularly in 
the context of vaccination with CpG DNA (7). However, as with other human immune 
pathologies, recent findings have suggested that Th17 cells profoundly participate in 
the pathogenesis of certain skin disorders, such as psoriasis or contact hypersensitivity 
(21). Hence, and before proposing a vaccination strategy that may enhance dermal 
Th17 expansion, we must rule out that the manipulation of dermal T-cell 
differentiation by our L. major/CpG DNA vaccine may result in the establishment of 
potentially pathogenic T cell lineages in the skin (i.e. activated Th17 lymphocytes) 
that could possibly enhance inflammation in susceptible individuals.  
In this report, we investigate the establishment of CD4+ memory cells in the 
skin of C57BL/6 mice vaccinated with L. major/CpG DNA, and their ability to 
produce cytokines once the vaccinated mice reach a chronic, immune stage. We also 
determined the effect of revaccination on the ability of resident memory T cells to 
produce the inflammatory cytokines IFN-γ and IL-17. Our data revealed that Th17 
producing memory T cells do not establish at the chronic site of Lm/CpG vaccinated 
mice, and that revaccination of these mice leads to an increase in IFN-γ, but not IL-17 
production, by memory CD4+ T cells. 
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Materials and Methods 
Mice 
Six-week-old C57BL/6 mice were purchased from Taconic (Germantown, 
NY). All mice were maintained in the Baker Institute for Animal Health animal care 
facility under pathogen-free conditions. All animal experiments were performed 
according to federal guidelines and institutional policies (animal protocol 2008-177). 
All efforts were made to minimize suffering. All animal work has been conducted 
according to relevant national and international guidelines. The work described in the 
manuscript has been approved by Cornell's IACUC committee (Protocol no. 2010-
0035). 
 
Parasites 
L. major clone V1 (MHOM/IL/80/Friedlin) promastigotes were grown at 26 
°C in medium 199 supplemented with 20% heat-inactivated fetal calf serum (Gemini, 
Sacramento, CA), 100 U/ml penicillin, 100 mg/ml streptomycin, 2 mM L-glutamine, 
40 mM HEPES, 0.1 mM adenine (in 50 mM HEPES) and 5 mg/ml hemin (in 50% 
triethanolamine).  
 
Infection protocol and vaccine preparation 
Infective-stage promastigotes of L. major were isolated from stationary 
cultures (4-5 days old) by Ficoll enrichment as described (22). Mice were vaccinated 
intradermally in ears with 104 L. major promastigotes with or without 50 mg CpG 
DNA (5’ TCC ATG ACG TTC CTG ACG TT-3’, IDT, Coralville, IA), using a 27G 
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needle in a volume of 10 ml.  The evolution of the lesions was monitored by 
measuring the diameter of the induration using a vernier caliper. 
 
Parasite titration 
Parasite loads in the ears were determined as described before (23). Briefly, the 
ear sheets were separated and deposited in DMEM containing Liberase CI enzyme 
blend (0.5 mg/ml) for 60 min at 37 °C. The sheets were then dissociated using a 
handheld tissue homogenizer. The homogenates were filtered using a 70-mm cell 
strainer (BD Falcon, San Jose, CA) to produce single cell suspensions and serially 
diluted in a 96-well flat-bottom microtiter plates containing biphasic medium prepared 
using 50 mL Novy-MacNeal-Nicolle (NNN) medium containing 20% of defibrinated 
rabbit blood overlaid with 100 mL medium 199. The number of viable parasites in 
each ear was estimated by limiting dilution from the highest dilution at which 
promastigotes could be grown out after 7 days of incubation at 26 °C. Parasite 
numbers were also determined in the local draining lymph node (submandibular). 
Lymph nodes were mechanically dissociated and parasite load was determined by 
limiting dilution as described above. 
 
Analysis of dermal lymphocytes 
Single-cell suspensions from the ear dermis were obtained as described above. 
For the analysis of surface markers and intracytoplasmic staining for cytokines, cells 
were stimulated overnight with 25 mg/mL soluble Leishmania antigen (SLA), 5 ng/ml 
IL-2 and 10 mg/ml anti-CD28, cultured with brefeldin A at 10 ng/ml for 6 h and then 
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fixed in 2 % paraformaldehyde (23). Prior to staining, cells were incubated with an 
anti-FcgIII/II receptor antibody and 10% normal mouse serum in PBS containing 
0.1% BSA, 0.01% NaN3. Cells were permeabilized and stained for the surface markers 
CD4 (clone GK1.5), TCR-β (clone H57-597), CD44 (clone IM7), CD62L (clone 
MEL-14), and for the cytokines IFN-γ (XMG1.2) and IL-17A (clone eBio17B7). All 
antibodies were purchased from BD Bioscience (San Jose, CA) or eBioscience (San 
Diego, CA). Incubations were carried out for 30 min on ice. For each sample, at least 
100,000 cells were analyzed. The data were collected and analyzed using BD 
FACSDiva or FlowJo software and a LSRII flow cytometer (BD Bioscience, San Jose, 
CA). 
 
Statistical analysis 
All comparisons of non-normally distributed continuous data were analyzed 
with Student’s T test, Mann-Whitney U test or ANOVA using GraphPad Prism (San 
Diego, CA).  
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Results 
Parasite persistence is achieved following live vaccination with L. major in the 
presence or absence of CpG DNA 
As previously reported, we vaccinated C57BL/6 mice in one ear with L. major 
alone (104) or in combination with 50 mg CpG DNA, and monitored them for 3 
months. As reported multiple times before (4, 5), mice vaccinated with the L. 
major/CpG DNA combination displayed a decrease in lesion size and accelerated 
healing compared with the animals vaccinated with parasites alone (not shown). After 
healing, the infection site of L. major becomes a chronic site characterized by parasite 
persistence in the absence of lesions (24). Figure B1 shows that, as expected, 
chronicity was achieved in all vaccinated ears. The parasite burden after healing was 
significantly reduced in the group vaccinated with L. major/CpG DNA (P = 0.004). 
Interestingly, a small number of parasites could also be detected in the opposite, naïve 
ears in both groups (216 ± 125 vs. 270 ± 108 for L. major and L. major/CpG DNA, 
respectively; these numbers were not statistically different). Parasites were also 
present in the submandibular lymph nodes draining from the vaccinated ears, although 
they could not be detected in the opposite site. Again, there was a slight reduction in 
numbers in the group vaccinated with CpG DNA (P = 0.04) 
 
CD4+ memory T cells produce IFN-γ but not IL-17 in the skin and draining 
lymph nodes of chronic, vaccinated mice 
We have previously reported that Th1, and particularly Th17 cells expand at 
the vaccination site of L. major/CpG DNA infection (7). We have not however  
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Figure B1. Live vaccination establishes a persistent infection in ears and draining 
lymph nodes. Mice were vaccinated in the ear dermis with 104 L. major promastigotes 
alone or in combination with 50 µg CpG DNA. Parasite burden (A) per ear and (B) per 
draining lymph node at 12 weeks post vaccination, expressed as geometric mean ± SD 
(n= three mice per group). **P = 0.004; *P = 0.04. N.D.= not detected. 
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investigated whether specific memory T cells are generated following the attrition of 
these populations during the acute phase of infection. We therefore studied the 
frequencies of tissue effector memory T cells (defined as TCRb+CD44+CD62Llow) in 
the ears and draining lymph nodes of chronic, vaccinated mice. In order to gain a 
comprehensive view of the function of these specific memory cells, we tested them for 
the production of IFN-γ and IL-17. Figure B2 shows that memory cells preferentially 
produced IFN-γ in both the ears and the lymph nodes of the vaccinated mice. No IL-
17+ CD4+ memory cells were detectable in any of the tissues analyzed. Although the 
frequency of IFN-γ+ cells was slightly reduced in the L. major/CpG DNA group if 
compared with the mice vaccinated with L. major alone, the absolute number analysis 
revealed that cytokine positive cells were elevated in this group (2618.9 ± 211.3) when 
compared with the number found in the ears of mice vaccinated with L. major alone 
(1977.2 ± 162.0, P=0.04), No differences in frequencies or absolute numbers of 
cytokine positive cells were found in the lymph nodes (not shown). 
 
Revaccination of vaccinated mice leads to an increase in IFN-γ, but not IL-17 
production, by memory CD4+ T cells 
The objective of our next experiment was to elucidate whether revaccination of 
chronic vaccinated mice would cause expansion of cytokine positive CD4+ T cells. 
Mice vaccinated with L. major alone in one ear were inoculated with 104 parasites 
alone or with the CpG DNA in the opposite ear 20 weeks following the initial 
vaccination. Similarly, mice vaccinated originally with L. major /CpG DNA were  
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Figure B2. CD4+ memory T cells of vaccinated mice produce IFN-γ, but not IL-
17. Comparative analysis of IFN-γ and IL-17 expression by CD4+ memory T cells 
extracted from ears and draining lymph nodes of mice vaccinated with 104 L. major 
alone or in combination with 50 µg CpG DNA. For each experiment, IFN-γ and IL-17 
producing cells extracted from ears and draining lymph nodes were analyzed on gated 
cells by flow cytometry (n=3 mice per group). Flow cytometry plots showing the 
frequency of IFN-γ and IL-17 producing CD4+ effector memory T cells 
(TCRβ+CD44+CD62Llow) in (A) ear and (B) draining nodes 12 weeks post 
vaccination. Data are expressed as mean ± SEM from three independent experiments. 
(C) Absolute numbers of IFN-γ and IL-17 producing CD4+ memory T cells in 
vaccinated ears at 12 weeks post vaccination. Data are mean ± SEM from three 
independent experiments. *P = 0.04 (L. major/CpG DNA versus L. major). 
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inoculated in the opposite ear with either parasites alone or together with CpG DNA. 
The frequencies and absolute numbers of memory CD4+ T cells producing IFN-γ or 
IL-17 were determined in the vaccinated (first site) and in the opposite ears (second 
site, revaccinated site) three days after the expansion. Figure B3. A shows that, three 
days after injection, the frequencies of IFN-γ+ CD4+ effector memory cells increased 
slightly (to ca. 10%). This frequency was higher than what previously found in the 
chronic, unchallenged stage (7.9 %, Figure B1), suggesting that the disturbance 
caused by revaccination in the chronic site led to the expansion, or new recruitment, of 
the IFN-γ+ CD4+ T cell population. This increase was detectable in both the vaccinated 
and the challenged sites, and took place irrespective of the vaccine type employed. 
The quantitative analysis of the absolute number revealed a 10-fold increase in the 
number of cytokine positive cells (Figure B3. B). This expansion was always greater 
in the primary site when compared with the revaccinated site, and was statistically 
significant. To determine if the enhanced response was L. major specific, we also 
inoculated some mice with an irrelevant antigen (i.e., ovalbumin (OVA)) as a control. 
Mice injected with OVA also displayed an increase in IFN-γ+ cells, although the 
absolute numbers were significantly reduced compared to the mice challenged with 
live parasites, suggesting that reinfection/inoculation with a non-leishmanial antigen 
would not cause a significant increase in IFN-γ+ cells. In contrast, the frequency of IL-
17+ effector memory cells did not change following revaccination, and in all cases 
remained below 1% (Figure B3. C). Analysis of the absolute numbers confirmed 
these conclusions and showed that although IL-17+ cells can be detected in the ear, 
their numbers were very low and not different from the chronic state. Finally, there  
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Figure B3. Revaccination leads to IFN-γ, but not IL-17 production by CD4+ 
effector memory T cells. Mice vaccinated with L. major alone or with the CpG DNA 
in one ear were inoculated with 104 parasites alone or with the CpG DNA or with 50 
µg OVA in the opposite ear at 20 weeks post vaccination. Three days after injection, 
IFN-γ and IL-17 expression by CD4+ memory T cells extracted from ears dermis were 
analyzed on gated cells by flow cytometry (three mice per group). (A) Flow cytometry 
plots showing the frequency of IFN-γ and IL-17 producing CD4+ effector memory T 
cells (TCRβ+CD44+CD62Llow) in both vaccinated and revaccinated ears. Data are 
expressed as mean ± SEM from three independent experiments. (B) and (C) Numbers 
of IFN-γ and IL-17 producing CD4+ memory T cells in both vaccinated and 
revaccinated ears. Data are expressed as mean ± SEM from three independent 
experiments. *P < 0.05 (First site versus second site). 
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was no expansion of cytokine positive memory cells in the draining lymph nodes (Fig. 
B5).  
Revaccinated mice were also monitored for the development of lesions for 14 
weeks. A group of naïve mice challenged with L. major were included in the 
experiment as a control. As expected, naïve mice developed lesions following 
infection, which healed after 14 weeks. Also as expected all non-naïve mice (already 
vaccinated with L. major with or without CpG DNA) developed a transient 
inflammation that resolved spontaneously, but did not develop lesions in the 
challenged site (Figure B4. A). Parasite burden at day 3 after revaccination was 
determined in both the vaccinated and the challenged ears. Figure B4. B shows that 
revaccination did not dramatically expand the number of parasites detectable in ears.  
  184 
 
 
Figure B4. Revaccinated mice did not develop lesions or increase parasite 
numbers in ears. Mice were vaccinated with L. major alone or with the CpG DNA in 
one ear. At 20 weeks, vaccinated mice were inoculated with 104 parasites alone (Lm), 
with the CpG DNA (Lm/CpG), or with 50 µg OVA in the opposite ear. (A) Lesion 
size at challenge ear was followed up to 14 weeks. Data are expressed as mean ± 
SEM, three mice with n=6 ears per group. (B) Parasite numbers at day 3 after 
revaccination per ear, expressed as geometric mean ± SEM, six ears per group. * P < 
0.01.  
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Figure B5. Frequency and numbers of IFN-γ and IL-17 producing CD4+ memory 
T cells in lymph nodes. Mice vaccinated with L. major alone or with CpG DNA in 
one ear were inoculated with 104 parasites alone (Lm), with CpG DNA (Lm/CpG), or 
with 50 µg OVA in the opposite ear at 20 weeks post vaccination. Three days after 
injection, IFN-γ and IL-17 expression by CD4+ memory T cells extracted from 
draining lymph nodes were analyzed on gated cells by flow cytometry (three mice per 
group). (A) Flow cytometry plots showing the frequency of IFN-γ and IL-17 
producing CD4+ effector memory T cells (TCRβ+CD44+CD62Llow) in both vaccinated 
and revaccinated lymph nodes. Data are expressed as mean ± SEM from three 
independent experiments. (B) and (C) Numbers of IFN-γ and IL-17 producing CD4+ 
memory T cells in both vaccinated and revaccinated lymph nodes. Data are expressed 
as mean ± SEM from three independent experiments. *P < 0.05 (First site versus 
Second site). 
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Discussion 
Compelling and accumulating evidence suggests that Th17 cells have evolved 
to mediate protective immunity against a variety of pathogens, primarily at mucosal 
sites. Our own data (7) and work by others (25-30) support the view that Th17 cells 
may be crucial players in the generation of vaccine-induced protective responses 
against pathogens. We recently published that intradermal vaccination of mice with a 
combination of L. major and CpG DNA modifies the immunological features of 
leishmanial infection to cause de novo expansion of Th17 cells in the skin (7). After 
our work was published, other authors have confirmed a role for Th17 cells in L. 
major infection (31) and as part of protective responses in vaccines against L. 
infantum (32). Th17 cells, however, have also been found to be present at the site of 
inflammation in some human inflammatory and autoimmune diseases (33). In 
particular, the presence of IL-17 in lesional skin in humans and data from mouse 
models suggest that IL-17 is pivotal in the pathogenesis of certain skin conditions such 
as psoriasis and contact hypersensitivity (21). Hence, it is paramount that we 
investigate whether our Th17 inducing live vaccine would establish a chronic 
population of this potentially pathogenic population in the skin.  
In this report, we have demonstrated that our live vaccine adjuvanted with CpG 
DNA did not cause the establishment of memory Th17 cells in the vaccination site or 
the draining lymph nodes. We have also shown that revaccination with live vaccines 
containing L. major, or inoculation of other antigens such as OVA, did not cause a 
recall increase of Th17 cells either, confirming that Th17 responses are transient and 
rapidly controlled following its initial expansion. We have hypothesized that, in our 
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model, Th17 cells may be negatively regulated immediately after their expansion by a 
sustained vaccine-induced production of IL-2 to favor the expansion and survival or 
regulatory T cells (6, 7). How attrition of this population of inflammatory cells takes 
place, and the factors involved, deserve further investigation. 
While no IL-17 producing cells were detected, we observed however an 
expansion of IFN-γ+ CD4+ memory T cells following revaccination with specific anti-
leishmanial vaccines or inoculation of irrelevant antigens such OVA. We have already 
reported that the proportion of effector cells increased during the effector immune 
response (24), so this expansion may have been a consequence of a transient recall 
response to an injection in the skin. Moreover, it is likely that these IFN-γ producing, 
activated effector memory cells would also produce other cytokines such as IL-2, 
contributing to the negative regulation of Th17 development in the skin.  
The potential for inflammatory and paradoxical complications should always 
be considered in the rational design of new vaccines, especially in the case of patients 
suffering other clinical conditions or comorbidities. The data shown here specifically 
demonstrate that potentially pathological Th17 cells are not chronically established at 
the site of L. major infection of vaccination, and it would be safe to use in patients 
predisposed to Th-17 mediated proinflammatory conditions.  
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